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ABSTRACT 
 
Exercise alone is an efficacious intervention for depression, but few studies have 
identified the benefits of using exercise to augment other psychosocial treatments.  The 
purpose of the current series of studies was to examine the feasibility, acceptability, 
efficacy, and potential mechanism of the augmentation of behavioral activation (BA) 
with exercise. The starting point for this series was a meta-analysis of the strength and 
reliability of brain-derived neurotrophic factor (BDNF) as a putative mechanism of the 
mood and cognitive effects of exercise.  Evaluating 29 studies, I found: (1) a moderate 
effect for BDNF increases following acute exercise, (2) a moderate effect for the 
intensification of this effect following a program of exercise, and (3) a small effect on 
resting BDNF following a program of exercise.  Given these effects, I hypothesized that 
exercise added to BA would improve mood beyond that for BA combined with a control 
condition and that changes in BDNF would mediate these effects.  In a clinical trial, 32 
sedentary, depressed patients received 9 sessions of BA over 12 weeks and were 
randomized to receive an exercise or control (stretching) augmentation.  Assessments of 
depression, quality of life, distress intolerance, perceived stress, cognition (memory, 
 viii 
attention), and amount of exercise were conducted across the treatment period.  Results 
demonstrated strong credibility ratings and completion rates comparable to other exercise 
interventions.  The randomized treatment failed to lead to differential exercise between 
groups; all participants exercised more over time.  Similarly, participants, regardless of 
condition, significantly improved on all outcome measures over time.  BDNF 
significantly increased following acute exercise.  However, the amount of exercise 
completed over time was not significantly related to changes in BDNF across acute 
episodes, nor did resting BDNF significantly improve over time. Nonetheless, effect sizes 
for these changes were in the moderate range, reflecting values for the literature as a 
whole. Finally, contrary to my hypothesis, BDNF changes were not associated with 
subsequent improvement in depression symptoms.  
Results from this trial raise questions whether BA may be a powerful enough 
intervention to increase exercise, thus explicit exercise prescriptions may not be 
necessary for patients receiving this intervention.   
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 1 
Chapter 1. General Introduction1 
Major Depressive Disorder (MDD) affects approximately 29.9% of adults in the 
United States (US) across the lifespan, and approximately 8.6% of adults per year 
(Kessler, Petukhova, Sampson, Zaslavsky, & Wittchen, 2012).  The World Health 
Organization (WHO) lists depression as the leading cause of disability for US adults ages 
15-44 (World Health Organization, 2004) and the 4th leading cause of disability 
worldwide (Murray & Lopez, 1996).  The costs of disability range from premature 
termination of education and teen childbearing to divorce, lack of financial success, and 
difficulties with job performance (Kessler, 2012).  Indeed, it is estimated that depression 
costs employers over $36 billion per year in absenteeism and lost productivity (Kessler et 
al., 2006). 
In addition to the psychosocial costs, MDD has been implicated as a cause or 
predictor of worse course of several medical disorders (Gillen, Tennen, McKee, Gernert-
Dott, & Affleck, 2001; Peyrot & Rubin, 1997), including cardiovascular disease, 
diabetes, hypertension, cancer, arthritis, asthma, chronic respiratory disorders, and 
chronic pain (Anderson, Freedland, Clouse, & Lustman, 2001; Buist-Bouwman, de 
Graaf, Vollebergh, & Ormel, 2005; Chapman, Perry, & Strine, 2005; Derogatis et al., 
1983; Nemeroff, Musselman, & Evans, 1998).  MDD also contributes to development of 
obesity (Cizza, 2011) and has been shown to lead to low treatment adherence for medical 
                                                     
1 This work was supported by grant F31 MH100773 from the National Institute of Mental 
Health. 
 
 
 
 
 2 
conditions (Schlenk, Dunbar-Jacob, & Engberg, 2004), thus conferring greater health 
risk.  Indeed, MDD is associated with risk of early death (Cuijpers & Schoevers, 2004). 
Given the prevalence, disease burden, and medical conditions associated with 
MDD, there is a significant need for efficacious treatment for this condition.  According 
to Division 12 of the American Psychological Association (Strunk), current first-line 
treatments for MDD include cognitive-behavioral therapy (CBT), interpersonal therapy, 
behavioral activation (BA), and problem-solving therapy as well as pharmacological 
treatments, primarily selective-serotonin reuptake inhibitors (SSRIs).  However, 
approximately 19-34% of depressed patients do not respond and 29-46% partially 
respond to antidepressant pharmacological treatment or CBT (Fava & Davidson, 1996).  
Furthermore, about half of individuals who meet criteria for MDD in a given year receive 
treatment for it, and only 21% of those individuals receive care consistent with the 
American Psychiatric Association (APA) Guidelines (Gonzalez et al., 2010).  
Additionally, the large-scale Sequenced Treatment Alternatives to Relieve Depression 
(STAR-D) trial has shown limited efficacy for combined or sequential treatment with 
antidepressants and CBT for patients failing to respond to initial interventions (Gaynes et 
al., 2008). 
The limited efficacy of antidepressants and CBT for treatment-resistant 
depression found in the STAR-D trial indicates a need for the investigation of alternative 
treatments that may be more beneficial and accessible for these individuals (Pigott, 
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Leventhal, Alter, & Boren, 2010). Programmed exercise may represent this viable 
alternative treatment for the treatment of depression. 
Exercise as an Intervention for Depression 
 Several population-based studies demonstrate the correlation between physical 
activity and mood.  For example, in a study of 55,000 adults in the US and Canada, lower 
symptoms of anxiety and depression were present among those with greater levels of 
physical activity (Stephens, 1988).  Similarly, a study of 3,403 adults in Finland showed 
that those who exercised 2-3 times per week evidenced less depression, anger, distrust, 
and stress and a better sense of social integration (Hassmen, Koivula, & Uutela, 2000).   
 Population-based studies and meta-analyses also suggest the possibility of a 
bidirectional, or possibly feed-forward, relationship between depression and sedentary 
behavior as depression can increase the risk for lack of physical activity.   For example, 
in a study across 36 countries, Stubbs and colleagues (2016) found that having depression 
increased the odds for engaging in less physical activity.  A meta-analysis of 24 studies 
found that people with MDD participated in less total physical activity and engaged in 
more sedentary behavior (Schuch, Vancampfort, Firth, et al., 2016) and approximately 
68% individuals with MDD did not meet the recommended guidelines for participation in 
physical activity. 
 Meta-analyses also document a causal relationship between exercise and mood 
enhancement.  For example, a meta-analytic review of 11 trials comparing exercise 
programs to non-active conditions for the treatment of depression found a large overall 
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between-group effect size indicating a strong advantage of exercise interventions over 
control conditions (Stathopoulou, Powers, Berry, Smits, & Otto, 2006).  A more recent 
meta-analysis of 35 trials found a moderate effect size (an approximate difference of 5 
Beck Depression Inventory points) between exercise and non-active control conditions 
(Cooney et al., 2013).  A third meta-analysis of 23 randomized controlled trials (RCTs) 
found a moderate to large effect size for exercise over non-active control conditions 
(Kvam, Kleppe, Nordhus, & Hovland, 2016).  Meta-analyses have also indicated benefits 
of exercise in enhancing mood for specific populations, such as adolescents (Radovic, 
Gordon, & Melvin, 2017) and older adults (Schuch, Vancampfort, Rosenbaum, Richards, 
Ward, Veronese, et al., 2016).  Additionally, in a meta-analysis of 6 RCTs, exercise was 
shown to not only improve physical and psychological domains of depression but also 
enhanced overall quality of life (Schuch, Vancampfort, Rosenbaum, Richards, Ward, & 
Stubbs, 2016).  Meta-analyses provide evidence that exercise improves mood in 
depressed patients with chronic medical conditions as well (Herring, Puetz, O'Connor, & 
Dishman, 2012). 
Though few studies have compared exercise to other active treatments, findings 
from a recent meta-analysis suggest that effects of exercise tend to be in a similar range 
to those of antidepressants and other psychological treatments.  When comparing exercise 
to psychological treatment (i.e., group cognitive therapy, group interpersonal therapy, 
individual CBT), results of three studies (n = 79) included in the meta-analysis indicated 
a small, non-significant effect in favor of exercise (Kvam et al., 2016). That is, exercise 
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was at least as efficacious as, and tended to be slightly more efficacious than, these 
interventions. Likewise, based on another three studies (n = 236), which compared 
exercise to antidepressant medication, there were no significant differential effects for 
improving depression symptoms.  However, there was a moderate, still non-significant, 
effect in favor of combined exercise and antidepressant treatment based on four studies (n 
= 188) relative to pharmacotherapy alone.   
Evidence for Exercise as an Adjunctive Intervention 
A recent review including 13 studies suggested a strong overall effectiveness of 
exercise combined with antidepressant treatment (Mura, Moro, Patten, & Carta, 2014).  
Exercise also may limit dosage requirements of certain antidepressants, like sertraline, 
when used as an adjunct to pharmacotherapy.  In a randomized controlled study of 57 
patients with MDD, Siqueira and colleagues (2016) found that individuals completing a 
4-week intervention including pharmacotherapy (i.e., sertraline) plus aerobic exercise 
required significantly lower dosages of sertraline compared to the monotherapy (i.e., 
sertraline only) condition to lower depression symptoms. 
Exercise has been shown to effectively target treatment-resistant depression, or 
those who were non- or partial-responders to SSRIs, as a sequential adjunctive 
application.  For example, after a 12-week randomized controlled exercise intervention of 
126 sedentary adults with treatment-resistant depression, patients in both high and low 
energy expenditure conditions reported significantly lower depression symptoms over 
time (Toups et al., 2011).  Participants in this study also improved on several 
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psychosocial and quality of life domains (e.g., health, employment, social adjustment; 
Greer et al., 2016).   
Exercise also appears to offer efficacy in combination with psychosocial 
treatments.  Kruisdijk and colleagues (2012) demonstrated that intense aerobic exercise 
as an addition to treatment as usual, defined as pharmacotherapy or psychotherapy, 
offered beneficial mood effects for MDD. Additional support for a combination treatment 
model is provided by a study of the combination of exercise with CBT for anxiety 
disorders. For example, in a randomized controlled trial, Merom and colleagues (2008) 
found that group CBT plus exercise significantly reduced depression, anxiety, and stress 
scores after 8-10 weeks of treatment compared to group CBT plus lifestyle education in 
individuals with panic disorder, generalized anxiety disorder, and social phobia.  Other 
studies support the use of adjunctive exercise for panic disorder.  A study of 47 patients 
with panic disorder found that those receiving group CBT plus aerobic exercise over the 
course of one month improved significantly more in anxiety scores than those in a control 
condition (Gaudlitz, Plag, Dimeo, & Strohle, 2015).  In a feasibility pilot study, including 
four participants, of combined internet-based CBT and two weekly sessions of 
unsupervised exercise, all participants reported acceptability of the treatment and several 
participants had significant decreases in depression and anxiety scores (Hovland et al., 
2015).  Similar pilot studies have been conducted examining the effects of exercise 
augmentation strategies for exposure therapy for PTSD (Powers et al., 2015) and for CBT 
for OCD (Rector, Richter, Lerman, & Regev, 2015) with preliminary effects indicating 
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greater improvement in PTSD symptoms and OCD symptoms, respectively, for those in 
the combined exercise conditions. 
Few RCTs have examined the combination of a strictly behavioral intervention 
and exercise for MDD.  One pilot trial of 29 female patients with comorbid MDD and 
Type 2 diabetes utilized a group exercise plus behavioral activation format to target 
depression over the course of 6 months (Schneider et al., 2016).  Exercise was conducted 
in group, supervised classes plus one at-home unsupervised session for a total of 150 
minutes of moderate-intensity exercise per week.  Behavioral activation content was 
provided following exercise and included components of Lejuez and colleagues’ (2011) 
recommendations including activity and mood monitoring, behavioral contracts with 
friend/family, and values and activities assessments.  Results of this study demonstrated 
feasibility of the treatment as indicated by strong retention rates (86.2% at 6 months).  
Though there were no differences between groups receiving exercise plus BA or 
enhanced usual care (i.e., referrals for depression treatment), depressive symptoms and 
self-reported physical activity increased over time.  Additionally, those in the exercise 
group reported greater exercise enjoyment and less avoidance behavior. 
Mediators and Moderators of the Effect of Exercise on Depression 
 The current literature provides ample support for the use of exercise in improving 
depression symptoms; however, the pathway by which exercise exerts its effects on mood 
remains unclear.  The study of mechanisms of action has become a priority in recent 
years and is listed as the first Strategic Objective outlined in the National Institute of 
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Mental Health (NIMH) Strategic Plan for Research (National Institute of Mental Health, 
2016; Insel, 2009).  In terms of the effect of exercise on depression symptoms, several 
mechanisms of action, both biological and psychological, have been hypothesized, as 
detailed in the following sections. 
Brain-derived Neurotrophic Factor 
 Brain-derived neurotrophic factor (BDNF) is a protein found in several areas of 
the central and peripheral nervous system, but is primarily located in the hippocampus.  
BDNF promotes neuro-plasticity, reduces neuro-degeneration, and stimulates cell 
survival (Cotman 2007).  Decreased levels of BDNF have been associated with 
impairments in the memory and learning functions of the hippocampus, including 
memory consolidation, storage, and long-term memory (Cirulli, Berry, Chiarotti, & 
Alleva, 2004; Roig, Nordbrandt, Geertsen, & Nielsen, 2013).   
Studies have found that individuals with depression evidence lower levels of both 
serum and plasma BDNF than healthy controls (Bocchio-Chiavetto et al., 2010; Brunoni, 
Lopes, & Fregni, 2008; Lee, Kim, Park, & Kim, 2007).  Furthermore, individuals 
undergoing antidepressant treatment show significant increases in BDNF expression from 
pre- to post-treatment (Piccinni et al., 2008; Russo-Neustadt & Chen, 2005; Sen, Duman, 
& Sanacora, 2008a).  
Studies have suggested that exercise exerts an effect on mood through increases in 
BDNF activity (Thomson et al., 2015; van Praag, Shubert, Zhao, & Gage, 2005; 
Vaynman, Ying, & Gomez-Pinilla, 2004; Voss, Vivar, Kramer, & van Praag, 2013).  A 
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recent review (Schuch, Dunn, Kanitz, Delevatti, & Fleck, 2016) noted that BDNF was 
one of two individual biological moderators, along with tumor necrosis factor alpha, for 
which higher baseline levels predicted greater or more rapid decrease of depression 
symptoms following exercise. This review also reported one study (Toups et al., 2011) 
with evidence of a composite moderator (i.e., the interaction between BDNF and BMI), 
which showed that those with higher levels of BDNF and higher BMI had more 
significant decreases in depression symptoms than those with higher BDNF and lower 
BMI.  The reason for this moderation is unclear, but may be explained either by study 
randomization (i.e., all those with high BMI were allocated to the high expenditure 
condition) or by the correlation between BMI and depression (i.e., as expenditure 
increases and baseline BMI decreases, depression symptoms may decrease as well).  
Overall, few studies have identified the effects of either acute or regular exercise on 
BDNF levels in psychiatric patients, thus, this population should be targeted for future 
research. 
Benefits of BDNF to Cognitive Deficits in Depression 
Depression is often characterized by cognitive deficits, particularly in memory 
(episodic memory and working memory; McDermott & Ebmeier, 2009) and attention 
(Rock, Roiser, Riedel, & Blackwell, 2013).  A recent meta-analysis found that 
neurocognitive deficits (e.g., impairments in executive functioning, processing speed, and 
verbal/visual memory) were associated with poorer scores on psychosocial measures of 
functioning and overall quality of life (Evans, Iverson, Yatham, & Lam, 2014).  
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Cognitive disruption is an important determinant of disability in depression that may not 
be well treated with pharmacotherapy or psychotherapy (Deckersbach et al., 2010; 
Wekking, Bockting, Koeter, & Schene, 2012).   
 Meta-analytic review indicates reliable improvements in cognition (attention and 
memory) with moderate-intensity exercise (McMorris & Hale, 2012; Smith et al., 2010), 
with some association between these changes and BDNF activity (Erickson, Miller, & 
Roecklein, 2012). Hence, one role for exercise, in addition to direct mood effects, is to 
improve cognition and potentially reduce disability in patients with depression.   
Stress Reactivity 
 Stress reactivity includes both physiological and psychological responses to 
stressful situations.  Several studies demonstrate the role of exercise in both athletically 
trained and untrained individuals in improving stress reactivity.  For instance, when 
exposed to a psychosocial laboratory stressor, trained male athletes exhibited 
significantly lower cortisol levels and heart rate than untrained men (Rimmele et al., 
2007).   Additionally, the trained athletes reported higher levels of calmness and better 
mood following the stressor.  In a study of 48 moderately physically fit women, a single 
bout of aerobic exercise attenuated blood pressure and heart rate responses to an acute 
stressor as compared to an attention control (Rejeski, Thompson, Brubaker, & Miller, 
1992).  Programs of exercise have also been shown to decrease stress response to a 
computerized simulated fire scene in firefighters (Throne, Bartholomew, Craig, & Farrar, 
2000). 
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 Few studies have identified the effects of exercise on stress response in depressed 
patients.  A study of 715 adolescents found that exercise was inversely related to 
affective symptoms of depression during a social stress test and that heart rate mediated 
this relationship (Booij, Bos, de Jonge, & Oldehinkel, 2015).  The mediation effect was 
likely due to exercise decreasing heart rate response across a variety of situations, 
including stressors.  Another study found that a four-month strength training exercise 
intervention reduced growth hormone response to acute exercise stress (an exercise test) 
in depressed patients (Krogh, Nordentoft, Mohammad-Nezhad, & Westrin, 2010). 
However, cortisol levels were not affected by strength training. Additionally, a single 
bout of exercise has been shown to aid in emotion regulation such that those who jogged 
for 30 minutes were able to generate more regulatory strategies and engage in more goal-
directed behaviors following a negative mood induction (Bernstein & McNally, 2016).    
Distress Intolerance 
 Distress intolerance (DI) is the inability to tolerate distressing states or 
experiences.   One facet of distress intolerance, anxiety sensitivity (AS), specifically 
measures the fear of anxiety-related somatic sensations, such as increased heart rate, 
shortness of breath, and sweating (McNally, 2002).  As exercise produces similar somatic 
sensations to those feared by individuals high in AS, exercise is viewed as a potential 
interoceptive exposure which may help reduce AS.   
 As such, several studies have targeted AS with exercise interventions.  For 
instance, in a study of 24 participants with high AS, those assigned to complete six 20-
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minute sessions of aerobic exercise evidenced significantly lower AS scores post-
intervention than those in the no-exercise control condition (Broman-Fulks & Storey, 
2008).  Smits and colleagues (2008) found that those randomized to a 2-week exercise 
intervention or an exercise plus cognitive restructuring intervention had reduced AS 
relative to a waitlist control condition on the order of a large effect size.  One study found 
that a single bout of exercise can reduce AS for at least a week of follow-up 
(LeBouthillier & Asmundson, 2015).  A recent RCT found that in a sample of 136 
sedentary, daily smokers, those with high baseline AS who received standard smoking 
cessation treatment plus CBT and exercise were more likely to remain abstinent than 
those in the control condition (Smits et al., 2016).  The hypothesized mechanism of 
action is that by reducing affective distress and the resulting AS, smokers are more easily 
able to quit smoking.  Another study which utilized running as an interoceptive exposure 
found that cognitive (catastrophic thoughts) and affective (feelings of anxiety) reactions 
were minimized over time in those with high AS, thus indicating these avenues as 
possible mechanisms of change (Sabourin, Stewart, Watt, & Krigolson, 2015). 
 Few studies identify the effect of reducing AS on depression.  There does appear 
to be a connection between high AS and suicidal ideation. The AS cognitive concerns 
subscale of the Anxiety Sensitivity Index has been identified as a risk factor and the AS 
physical concerns subscale a protective factor in suicidal ideation and suicide attempts 
(Allan et al., 2015).   
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 The overarching factor of DI, which includes components of AS, seems to be an 
important variable in the treatment of depression, though less research has focused on this 
area in mood disorders than in anxiety disorders.  One study found that, in samples of 75 
and 34 patients participating in RCTs of an internet-based CBT program (iCBT), DI was 
associated with higher depression and psychological distress scores (Williams, 
Thompson, & Andrews, 2013).  The iCBT program significantly reduced depression, 
psychological distress, and DI; however, those with high DI scores at baseline had worse 
outcome scores following the treatment.  Though the impact of depression on DI and 
exercise has not been explicitly examined, the combination of depression and high DI 
impacts several other health behaviors.  These include alcohol use (Brooks Holliday, 
Pedersen, & Leventhal, 2016), risky sexual behavior (Tull & Gratz, 2013), and the 
management of HIV (O'Cleirigh, Ironson, & Smits, 2007) among others. 
Behavioral Activation 
 Behavioral activation is an empirically-supported treatment in which depressed 
patients engage in rewarding, adaptive activities and reduce involvement in behaviors 
maintaining depression symptoms (Dimidjian et al., 2006).  A meta-analysis of 20 studies 
found that behavioral activation enhances overall well-being (Mazzucchelli, Kane, & 
Rees, 2010).  Another meta-analysis found that activity scheduling, the primary 
component of behavioral activation, produced effect sizes similar to both cognitive 
therapy and antidepressant medication (Cuijpers, van Straten, & Warmerdam, 2007).  
Individual studies have found that behavioral activation implemented in 5-10 session 
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formats have reduced depressive symptoms in a variety of populations, including 
psychiatric inpatients (Hopko, Lejuez, LePage, Hopko, & McNeil, 2003), smokers 
(MacPherson et al., 2010), patients with borderline personality disorder (Hopko, Sanchez, 
Hopko, Dvir, & Lejuez, 2003), and individuals with obesity (Pagoto et al., 2008).  A 
recent trial demonstrated benefit of behavioral activation in just four sessions with 
improvements in depression and rumination over time (Moshier & Otto, 2017). 
 Exercise interventions targeting mood exhibit many similarities to traditional BA 
interventions.  At their heart, each intervention aims to increase overall activity despite 
the presence of negative affect.  In this way, both target anhedonic symptoms of 
depression as well as depressed mood.  Additionally, motivation enhancement strategies 
for exercise interventions, particularly those described by Otto and Smits (2011), often 
mimic problem-solving strategies utilized in BA to increase success in completing the 
scheduled activity.  Indeed, studies have also demonstrated increased behavioral 
activation following exercise interventions.  One such study found increases in 
components of behavioral activation, motivation and energy, as well as increased 
pleasure with more exercise (Toups et al., 2017).  Another pilot study of the feasibility of 
motivational interviewing plus a 12-week exercise intervention found lower depression 
symptoms and increased behavioral activation among all twelve participants in this pilot 
non-randomized trial (Nasstasia et al., 2016). 
Summary  
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 Overall, several biological and psychological mechanisms of action may underlie 
the effect of exercise on depression symptoms.  Quantitative and qualitative reviews as 
well as individual studies show that BDNF reliably increases following acute exercise, 
though changes in resting BDNF levels across programs of regular exercise are less 
reliable.  BDNF has also been reliably shown to increase following administration of 
antidepressant medications, and BDNF levels are lower in untreated depressed 
individuals.  Given the few studies examining the effect of exercise in psychiatric 
populations, this is an area that necessitates further study. 
 Stress reactivity represents both a biological and psychological mechanism of 
change.  Though acute and programmed exercise has been shown to decrease stress 
reactivity, few studies have been completed in psychiatric, and particularly depressed, 
populations. 
 Psychological mechanisms of change, such as distress intolerance, also reliably 
improve with exercise.  Though several studies identify the impact of exercise in 
reducing distress intolerance, particularly anxiety sensitivity, in anxious populations, few 
have been conducted with depressed patients.  On the other hand, behavioral activation 
treatments have been shown to be efficacious in reducing depression; however, more 
research on the combination of behavioral activation and exercise needs to be completed. 
Adherence Issues in Prescribing Exercise for Depression 
In general, 75% of Americans do not engage in regular physical activity, making 
motivation to exercise a potential obstacle during treatment (Flegal, Kruszon-Moran, 
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Carroll, Fryar, & Ogden, 2016) and suggesting that exercise as a treatment option for 
depression could be of benefit to many people who are not currently engaging in regular 
exercise.  One possible explanation for the high rates of sedentary behavior is the 
substantial delay between participating in exercise and realizing health benefits or bodily 
changes.  Moreover, participating in exercise for the sole benefit of reducing possible 
medical complications (e.g., cardiovascular disease) represents a probabilistic outcome.  
Research shows that individuals will often choose a small, definite reward (not having to 
put forth effort to engage in exercise) over a large, probable reward (reduction in risk for 
cardiovascular disease; Epstein, Salvy, Carr, Dearing, & Bickel, 2010).   
Role of Exercise in Combination with Brief Behavioral Activation for Depression 
 Behavioral activation treatment offers an ideal format for overcoming these 
obstacles and enhancing adherence to an exercise regimen.  For example, applying the 
BA framework of participating in activities to enhance mood overcomes the challenging 
contingency of participating in exercise for the sole purpose of health benefits.  In fact, 
studies have shown that mood improvements occur as early as five minutes after exercise 
and can last for several hours (Bartholomew, Morrison, & Ciccolo, 2005).  This rationale 
of exercise for mood along with several behavioral strategies for enhancing motivation is 
reviewed in Otto & Smits’ (2011) Exercise for Mood and Anxiety.  These strategies 
which include combining motivations, creating habits, using contextual cues, and 
breaking down activities into their component parts all receive attention in the self-
monitoring of mood and daily activities, scheduling activities that bring patients a sense 
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of pleasure or mastery, and identifying and reducing avoidance behaviors that increase 
depressive symptoms that define BA interventions. Confidence in adequate patient 
adherence to self-guided exercise sessions is enhanced by the results of recent trials 
showing excellent adherence for individuals with high levels of depression, despite 
failure of previous treatment interventions (e.g., Mota-Pereira et al., 2011).  Similarly to 
the rationale for BA, as patients experience more satisfaction and progress towards their 
exercise goals, they may experience a feed-forward cycle in which they continue to 
exercise (Baldwin, Baldwin, Loehr, Kangas, & Frierson, 2013). 
The Current Project 
 Given the large proportion of individuals diagnosed with depression in their 
lifetimes and the high percentage of individuals who only partially respond to treatment, 
the identification of novel treatment strategies as well as mechanistic targets for change 
to create more personalized approaches are of the utmost importance.  The overarching 
aim of this multiple-study investigation was to examine the feasibility, acceptability, and 
efficacy of a novel adjunctive exercise intervention as well as several biological and 
psychological mechanisms of change. 
 Study 1 (described in Chapter 2) explored the effect of exercise on one of the 
hypothesized mechanisms of action for exercise effects on depression: brain-derived 
neurotrophic factor (BDNF).  This study represented the first comprehensive quantitative 
meta-analysis to identify the effect of both acute and regular exercise on release of 
BDNF.  Changes in pre- to post-exercise BDNF levels were assessed following an acute 
 
 
 
 
 18 
bout of exercise as well as programmed regular exercise.  Additionally, the effects of 
programs of exercise on resting BDNF levels were assessed.  
 Study 2 (described in Chapters 3 and 4) incorporated BDNF mediation into a 
larger pilot randomized controlled trial.  This trial aimed to identify the effects of 
augmenting brief BA treatment for depression with an exercise intervention versus a 
stretching control.  Chapter 3 details the effects of this combined intervention on 
depression symptoms, quality of life, and cognition (i.e., attention and memory).  
Additionally, Chapter 3 investigated psychological mechanisms of action, including 
distress intolerance and perceived stress.  Chapter 4 examined the effects of exercise on 
change in BDNF and the subsequent changes in depression symptoms.   
 Together, these studies aim to provide preliminary evidence of a novel and easy to 
disseminate exercise intervention that may be beneficial to improving depression 
symptoms and quality of life, and to examine the potential mechanisms of action for this 
treatment.  The final chapter (Chapter 5) describes perspectives on extending this area of 
research to larger trials as well as utilizing the results in creating more personalized 
approaches to intervention.  Recommendations are made for future research and clinical 
implications are discussed.  
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Chapter 2. A Meta-Analytic Review of the Effects of Exercise on Brain-Derived 
Neurotrophic Factor2 
 There is a wealth of evidence that exercise improves both cognition (Roig et al., 
2013; Smith et al., 2010) and mood (Josefsson, Lindwall, & Archer, 2014; Rethorst & 
Trivedi, 2013; Stathopoulou et al., 2006), with evidence suggesting that brain-derived 
neurotrophic factor (BDNF) activity may mediate these effects (Erickson et al., 2012; 
Heyman et al., 2012; van Praag et al., 2005; Vaynman et al., 2004).  BDNF is a protein 
found in high concentrations in the central nervous system, primarily in the brain regions 
of the hippocampus, cerebral cortex, hypothalamus, and cerebellum (Murer, Yan, & 
Raisman-Vozari, 2001).  Central BDNF can cross the blood-brain barrier and therefore be 
stored in other areas of the body; however, BDNF can also be produced by tissues in the 
periphery, making it difficult to identify in humans whether BDNF changes in serum 
levels result from changes in central or peripheral BDNF (Erickson et al., 2012; Murer et 
al., 2001).  BDNF has been implicated in neural development and functioning, including 
neurogenesis, dendritic growth, and long-term potentiation of neurons (Altar, 1999; 
Gorski, Zeiler, Tamowski, & Jones, 2003; Huang et al., 1999; Lu, Pang, & Woo, 2005).  
Non-quantitative reviews from both the animal and human literature (Huang, Larsen, 
Ried-Larsen, Moller, & Andersen, 2014; Zoladz & Pilc, 2010) provide evidence that 
BDNF increases following exercise in rodents and acute and programmed aerobic 
                                                     
2 This chapter was originally published as “Szuhany, K. L., Bugatti, M., & Otto, M. W. 
(2015). A meta-analytic review of the effects of exercise on brain-derived neurotrophic 
factor. Journal of psychiatric research, 60, 56-64.”  It has been reprinted here with 
permission from the publisher, Elsevier. 
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exercise in humans.  Animal models provide more consistent evidence for exercise-
induced upregulation of BDNF, given the ability to measure BDNF centrally; however, 
studies indicate that peripheral (serum and plasma) and central BDNF levels are 
correlated in mouse models (Angelucci, Gelfo, De Bartolo, Caltagirone, & Petrosini, 
2011; Karege, Schwald, & Cisse, 2002), with some evidence for similar associations in 
humans (Krabbe et al., 2007). There is also tentative evidence that peripheral levels of 
BDNF may have central effects (Schmidt & Duman, 2010).  Given the evidence for 
BDNF increases, exercise can be viewed as a potential strategy for inducing BDNF 
activity for application to the enhancement of mood or cognition. 
Indeed, individual studies have demonstrated the effect of higher BDNF levels on 
numerous cognitive processes.  For example, higher BDNF levels have been associated 
with better spatial (Erickson et al., 2009; Rex et al., 2006), episodic (Egan et al., 2003), 
recognition (Komulainen et al., 2008; Whiteman et al., 2014), and verbal memory 
(Grassi-Oliveira, Stein, Lopes, Teixeira, & Bauer, 2008) as well as better hippocampal 
functioning (Erickson et al., 2012).  In addition, decreased levels of BDNF, particularly 
in older adults, have been associated with hippocampal atrophy and may contribute to 
memory impairment, which may be linked to cognitive challenges experienced in 
Alzheimer’s (Erickson et al., 2012; Murer et al., 2001).   
 Qualitative reviews (e.g., Huang et al., 2014; Zoladz & Pilc, 2010) present 
significant evidence that exercise enhances BDNF levels; however, they do not provide 
the magnitude or reliability of this effect.  The goal of the present quantitative meta-
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analytic investigation was to document the level and reliability of the effect of exercise 
on changes in BDNF activity in humans.  Three distinct paradigms have been used to 
study this effect: (1) changes in BDNF levels across a single session of acute exercise, (2) 
changes in BDNF levels across a session of exercise following a program of regular 
exercise (showing changes in BDNF release following repeated bouts of exercise), and 
(3) changes in resting BDNF levels following a program of regular exercise.  Each of 
these was examined separately due to evidence that the effects of exercise on BDNF vary 
across paradigms (Huang et al., 2014).   In the current meta-analysis, potential 
moderators (e.g., sex, age, assay type, diagnostic status, and exercise frequency) of the 
effect of exercise on BDNF were investigated.   
Materials and Methods 
Search strategy 
Studies published in English through February 2013 were identified using the 
search engines PubMed, PsycINFO, and Google Scholar.  The following search terms 
were used in combination: brain-derived neurotrophic factor, BDNF, exercise, and 
physical activity.  Reference sections of identified articles and relevant reviews were also 
examined to detect articles not captured by this search. 
Study selection and data abstraction 
Identified studies were selected for inclusion in analyses based on the following 
criteria: (1) focus on a human population, (2) use of a precise measure of BDNF 
concentration levels (i.e., plasma or serum), and (3) administration of an exercise 
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procedure or measure (i.e., acute exercise test, programmed regular exercise).  If levels of 
BDNF were not able to be determined in the text of the article, such data were requested 
from the study authors.  In the current report, data were abstracted from the articles by 
one of the first two authors and independently checked for accuracy.  Any inconsistencies 
regarding inclusion or data extraction were resolved in a consensus meeting with the 
senior author. 
Study characteristics 
Within each of the identified studies, several variables were evaluated to 
determine if they moderated the association between exercise and changes in BDNF 
levels from pre-exercise to post-exercise.  These included sex (expressed as % female), 
age, assay type (i.e., serum or plasma), diagnostic status, and exercise frequency (defined 
as greater than or equal to American College of Sports Medicine guidelines, Garber et al., 
2011).  
 Most studies of programmed exercise included for analysis involved a training 
program of aerobic exercise (n = 15); however, five studies included strength or 
resistance training, with two studies examining both strength and endurance (aerobic) 
training.  Aerobic exercises varied among programs, with some programs combining 
multiple exercises, in the following frequencies: cycling (n = 8), running (n = 5), walking 
(n = 3), swimming (n = 1), rowing (n = 1), and unspecified/individualized (n = 4).  Most 
programs required supervised training sessions (n = 16), whereas a few offered home-
based interventions (n = 2).  All but one of the programs that reported exercise intensity 
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required moderate intensity exercise, with the other program involving high intensity 
exercise.  Several studies compared a training vs. sedentary control (or other active 
control, such as stretching) group (n = 9); eight studies utilized within-subject designs.   
Data synthesis 
Random-effects analyses were used in this meta-analysis.  Random-effects 
analyses are considered to be superior to fixed-effects methods, which assume 
homogeneous population effect sizes, due to minimization of type I error rates (Hunter & 
Schmidt, 2004; Lipsey & Wilson, 2000) and more realistic representations of 
heterogeneous effect sizes in the population (Field, 2001). 
 Effect sizes were calculated using Hedges’ g (Hedges & Olkin, 1985), a variation 
of Cohen’s d that corrects for biases due to sample sizes.  To keep samples independent, 
one estimate of effect size was used per study; if a study included multiple effect sizes for 
a single construct, these effect sizes were averaged prior to data synthesis with other 
studies.  Effect sizes of exercise at different intensities were averaged for overall study 
effect size; however, control groups (e.g., stretching) were not included in the overall 
effect size.  We completed a separate moderator analysis of active (e.g., stretching) 
versus non-active (e.g., sedentary, waitlist) control groups, which revealed no moderation 
effects of control group type across paradigms (Q(1) = 0.06, p = 0.81) or within paradigm 
(all p > 0.07).  Analyses were conducted combining both aerobic and strength/resistance 
training as well as with strength/resistance training examined separately, given the 
potential differential effect of these styles of interventions.  Effect sizes were interpreted 
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in the following manner: small effect (g = 0.2), medium effect (g = 0.5), and large effect 
(g = 0.8), based on Cohen’s (1992) standards.   
For categorical moderators (e.g., assay type, diagnostic status, exercise 
frequency), effects were tested by computing Q tests to evaluate if effects varied 
systematically between groups.  For continuous moderators (e.g., sex, age), we used 
bivariate correlational analyses to evaluate significance. 
 Finally, publication bias was assessed.  Publication bias allows for protection 
against the “file drawer effect,” which posits that studies with null findings are less likely 
to be published and therefore unrepresented in the literature search and following meta-
analysis.  We evaluated publication bias using multiple methods.  First, we examined the 
fail-safe N, which determines the number of additional studies with a null result required 
to reduce the overall effect size to non-significance (Rosenthal, 1991; Rosenthal & 
Rubin, 1988).  If the fail-safe N is greater than 5 times the number of studies in the 
analysis, the results can be interpreted as robust (Rosenthal, 1991).  Second, we visually 
inspected the funnel plot for symmetry relative to the mean effect size.  Greater 
symmetry indicates lesser likelihood of publication bias.  All data analyses were 
conducted using Comprehensive Meta-Analysis Software (Bornstein, Hedges, Higgins, & 
Rothstein, 2005). 
Results 
Trial flow 
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A total of 61 studies was initially identified as likely meeting inclusion criteria; 
evaluation of these studies resulted in a final sample for analysis that included 29 studies 
(see Figure 1). Studies were excluded when sufficient data were not available (following 
several contact attempts with authors), when outcomes were not based on BDNF levels 
following a bout of exercise, or when BDNF genotypes rather than levels were assessed.  
 Table 1 displays the characteristics of the 29 studies, representing 1,111 
participants (mean age = 42.1, % female = 46.6%), included in the analysis. Fourteen 
studies (48%) examined changes in BDNF levels after a single session of exercise, eight 
studies (27%) examined changes in BDNF levels immediately post-exercise in a design 
evaluating the effects of a program of regular exercise, and thirteen studies (45%) 
examined changes in resting BDNF levels following a program of regular exercise. Four 
studies included patients with a diagnosis of a mental disorder: three of individuals with 
major depressive disorder (Gustafsson et al., 2009; Laske et al., 2010; Toups et al., 2011) 
and one of  individuals with panic disorder (Strohle et al., 2010).  Of these studies, three 
examined the effect of acute exercise (Gustafsson et al., 2009; Laske et al., 2010; Ströhle 
et al., 2010), whereas one (targeting depression) examined the effect of programmed 
exercise on resting BDNF levels (Toups et al., 2011). 
Effect of acute exercise on BDNF levels 
Figure 2 shows the effect sizes for the 14 studies analyzing the effect of acute 
exercise on change in BDNF levels.  For these studies, BDNF levels were measured prior 
to and following (from immediately to 60 minutes after) a single exercise session in the 
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laboratory.  Pre- to post-exercise change in BDNF levels across a single exercise session 
reflected a moderate effect size (Hedges’ g = 0.46, SE = 0.08, 95% CI = 0.29-0.62, z = 
5.49, p < 0.001). 
Effect of programmed regular exercise on BDNF levels 
The effect of programmed regular exercise on BDNF levels was examined for two 
different outcome variables.  First, we examined the effect of a program of regular 
exercise, ranging from 3 to 24 weeks, on changes in BDNF levels across a single session 
of exercise.  In a sample of 8 studies, pre- to post-exercise change in BDNF levels 
intensified following a program of regular exercise (Hedges’ g = 0.58, SE = 0.25, 95% CI 
= 0.10-1.07, z = 2.35, p = 0.02).  Results are displayed in Figure 3. 
 Second, we examined the effect of a program of regular exercise, ranging from 3 
weeks to 2 years, on resting BDNF levels.  In a sample of 13 studies, programs of 
exercise also exhibited changes in resting levels of BDNF; however, this result was on 
the order of a small effect size (Hedges’ g = 0.28, SE = 0.10, 95% CI = 0.08-0.48, z = 
2.79, p = 0.005).  Results are displayed in Figure 4. 
Effects of strength training on BDNF levels 
Removing a resistance paradigm (i.e., arm and elbow strength) from examination 
of effects of acute exercise on BDNF levels did not significantly impact the results 
(Hedges’ g = 0.49, SE = 0.08, 95% CI = 0.34-0.64, z = 6.48, p < 0.001).  However, 
removing a resistance training intervention from the effect of programmed exercise on 
acute BDNF levels reduced the effect size previously observed (Hedges’ g = 0.26, SE = 
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0.15, 95% CI = -0.03-0.54, z = 1.78, p = 0.075), potentially due to the very large effect 
size obtained in the removed study (g = 3.53).  Finally, removing one strength training 
study and two strength/resistance training study groups did not significantly affect the 
observed effect for resting BDNF levels following programmed exercise (Hedges’ g = 
0.29, SE = 0.10, 95% CI = 0.09-0.50, z = 2.82, p = 0.005). 
 When examining the five studies which included strength/resistance training 
groups, the effect did not reach significance (Hedges’ g = 0.57, SE = 0.41, 95% CI = -
0.24-1.37, z = 1.39, p = 0.17), perhaps due to two studies exhibiting moderate to strong 
positive effects and three studies exhibiting negative effects. 
Moderators of exercise effects on BDNF levels 
Of the moderators of interest, the proportion of women in studies, participant age, 
and assay type (i.e., serum or plasma) were not confounded with the type of exercise 
program. Across all studies, we found a significant negative correlation between effect 
size and percentage of women in studies (r(33) = -0.38, p = 0.03).  Effect sizes were 
smaller for studies with a greater proportion of women and retained significance when 
the one outlying effect size estimate (g = 3.53) was excluded from the analysis (r(32) = -
0.37, p = 0.04).  Across all studies, participant age was not significantly related to 
changes in BDNF levels following exercise (r(32) = -0.24, p = 0.19), nor was assay type 
(serum or plasma; Q(1) = 0.54, p = 0.46). 
The potential moderators of diagnostic status and exercise frequency were 
specific to the type of exercise paradigm; hence, the latter variables were examined only 
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within the relevant paradigms, albeit at low power.  Within studies of resting BDNF 
levels, exercise frequency category was not significantly related to BDNF levels (Q(1) = 
0.001, p = 0.98).   Of note, effect sizes for two psychiatric samples studied (major 
depressive disorder and panic disorder) were at least that of healthy samples for both 
acute exercise (0.49 for psychiatric versus 0.40 for healthy; Q(1) = 0.86, p = 0.36) and 
resting BDNF following regular exercise (0.40 for psychiatric versus 0.17 for healthy).  
Publication bias 
Publication bias was evaluated separately for each of the three paradigms 
examined.   
Acute exercise. Evaluation of publication bias indicated that 191 studies 
reporting a null effect would be required to shift the observed effect to a non-significant 
level.  A fail-safe N of 191 is substantially greater than the number of studies needed for 
a robust effect (N = 80) according to guidelines suggested by Rosenthal (1991), 
indicating that our effect is robust for this paradigm.  Also, the funnel plot is for this 
paradigm is roughly symmetrical by visual inspection (see Supplemental Materials). 
Programmed regular exercise.  The fail-safe N of 50 for the effect of 
programmed regular exercise on BDNF levels immediately following exercise equaled 
the number of studies needed for a robust effect (N = 50), and the funnel plot appeared 
roughly symmetrical by visual inspection.  Finally, the fail-safe N of 54 for the effect of 
programmed regular exercise on resting BDNF levels was marginally less than that 
needed for a robust effect (N = 80).  The funnel plot also appears asymmetrical with more 
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studies with small sample sizes appearing above the mean than below the mean, 
indicating that studies with smaller sample sizes are more likely to get published if the 
effect sizes are greater.  Funnel plots are presented in Supplemental Materials. 
Discussion 
 This meta-analysis provides reliable evidence that both acute and regular exercise 
have a significant impact on BDNF levels.  Evidence from 14 studies indicated that a 
single session of exercise increases BDNF levels, reflecting a moderate effect size.  
Moreover, regular exercise intensifies the magnitude of these effects with increased 
BDNF responsivity, reflecting a moderate effect size, following a regular program of 
exercise relative to those completing acute exercise alone. Both of these findings are 
reliable as evaluated by fail-safe N and funnel plot analyses. Finally, 13 studies 
demonstrated that programs of regular exercise also impact resting BDNF levels; 
however, this effect was more modest than that seen immediately after exercise, and this 
effect was not considered robust.   
 Considering these findings, there is reliable evidence from human studies 
indicating that each episode of exercise results in a “dose” of BDNF activity and that the 
magnitude of this “dose” can be enhanced over time by regular exercise.  The relative 
importance of these episodic BDNF doses, relative to the more subtle increases in resting 
BDNF levels seen across an exercise program, is not clear. Much more information is 
needed on the time course of benefits from exercise, particularly cognitive benefits, and 
the potential importance of BDNF activity at the time of learning, rather than as a general 
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prime in the days before a learning task (Korol, Gold, & Scavuzzo, 2013). Moreover, the 
staying power of brief exercise interventions needs to be elucidated, particularly given 
evidence in animal models that cognitive gains from brief exercise training (e.g., 4 
weeks) can be lost within several weeks (e.g., Hopkins, Nitecki, & Bucci, 2011).   
 More generally, animal studies provide evidence for a variety of mechanisms by 
which BDNF enhancement from exercise results in improved cognition.  For example, as 
little as one week of exercise improves subsequent learning in animals, an effect that is 
eliminated by blockade of BDNF in the hippocampus (Vaynman et al., 2004). Also, 
exercise-induced BDNF activity can reduce the threshold for successful encoding and 
memory (Intlekofer et al., 2013) and has been hypothesized to place the brain in a state of 
readiness for plasticity (Cotman, Berchtold, & Christie, 2007). The precise mechanism of 
this readiness is made challenging by the host of pre-synaptic enhancement of 
neurotransmitter release and post-synaptic N-methyl-D-aspartate receptor (NMDA) and 
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor changes as 
well as important downstream activity (e.g., cAMP response element-binding protein; 
CREB) associated with exercise-induced BDNF activity (Christie et al., 2008; Vaynman 
et al., 2004), all of which could play a role in long-term potentiation effects.  In addition, 
in terms of longer-term structural changes, exercise appeared to reverse hippocampal 
degeneration and declining hippocampal network efficiency in aged animals, with 
enhancement of presynaptic densities and greater connectivity (Siette et al., 2013).  These 
changes appear to explain the observed improvements in recognition memory associated 
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with exercise in animals (Cotman et al., 2007). In addition to the rescue of hippocampal 
neurons from the negative effects of aging, exercise-induced BDNF activity helps reduce 
the effects of specific stressors, including oxidative DNA changes (Yang, Lin, Chuang, 
Bohr, & Mattson, 2014) and disruption of synaptic plasticity from sleep deprivation 
(Zagaar, Dao, Alhaider, & Alkadhi, 2013).  Also, relative to models for cognition, models 
for exercise-induced BDNF effects on mood have undergone only limited development, 
drawing from the stress-protective aspects of BDNF, as well as the effects of 
antidepressant medications on BDNF (for review, Duman & Monteggia, 2006), but 
otherwise not offering detailed mechanisms.  Greater specification of the role of BDNF in 
mood disorders awaits additional study.  
 Concerning human studies, we had limited power to examine moderating 
influences of interpersonal and exercise characteristics, due to the limited sample size 
within each of the exercise paradigms investigated.  When examining moderators across 
paradigms, sex significantly moderated the effect of exercise on BDNF levels, such that 
BDNF did not increase as much in females following exercise as in males.  Given these 
data, we encourage further evaluation of this discrepancy in BDNF production and the 
use of sex as a covariate to hone the evaluation of exercise effects on BDNF, as well as 
outcomes assumed to be mediated by BDNF activity. 
Also of interest is the magnitude of exercise effects on BDNF levels for 
psychiatric populations and healthy populations.  In our meta-analysis, effect sizes 
between these populations were in similar ranges for acute exercise, but raised the 
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question whether regular exercise may have greater effects in psychiatric than healthy 
participants, given a tentative 2:1 difference in mean effect sizes for BDNF changes 
across exercise (0.40 for psychiatric versus 0.17 for healthy).  More studies are needed to 
see if these potential differences become reliable.  Yet, our tentative results raise the 
possibility that programs of exercise may help rescue the low resting BDNF levels often 
observed in depressed patients (Brunoni et al., 2008; Piccinni et al., 2008) and exercise 
produces effects in a similar range to those of antidepressants (d = 0.62 for 
antidepressants, Sen, Duman, & Sanacora, 2008b).  Future research may also focus on 
differences in exercise effects on BDNF in populations with medical conditions.  In our 
meta-analysis, we did not find significant differences between healthy individuals and 
those with medical conditions (e.g., obesity, MS, diabetes), but conclusions are limited 
due to few studies examining medical populations. 
Future studies also need to examine the effects of strength/resistance training on 
BDNF levels in comparison to effects of aerobic exercise on BDNF levels.  Our meta-
analysis had limited power to assess these affects due to the small number of studies 
including strength training.  These studies also included considerable variation in the 
strength and direction of effects, with three studies indicating negative effects of strength 
training (Correia et al., 2010; Schiffer, Schulte, Hollmann, Bloch, & Struder, 2009; Swift 
et al., 2012) on BDNF levels and two studies indicating positive effects (Goekint et al., 
2010; Yarrow, White, McCoy, & Borst, 2010), with one of these studies showing a very 
large positive effect (Yarrow et al., 2010).  Given the importance of both aerobic and 
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strength exercises in an exercise program, it would be beneficial to identify BDNF 
changes across both paradigms. 
Other potential moderators for future study include exercise intensity (e.g., mild, 
moderate, vigorous), sedentary status (e.g., sedentary, regular exercise completer, 
athlete), and genotype (e.g., val66met) as well as further investigating the potential 
negative association between age and effect size.  Exercise intensity was reported in 
several studies as estimated % of VO2max.  However, several studies failed to report 
intensity and many studies only evaluated moderate intensity exercise.  Future studies 
should clearly report exercise intensity level, utilizing estimated metabolic equivalents 
(METs) in order to better uniformly describe results.  In addition, future studies should 
consider investigating the effect of varying degrees of exercise intensity on BDNF 
production. Sedentary status (as quantified by the  Physical Activity Recall 
Questionnaire: (Blair et al., 1985); or the International Physical Activity Questionnaire: 
(Craig, Marshall, Sjostrom, et al., 2003)) and genotype expressions were rarely reported 
in detail in the studies examined, therefore, making these variables difficult to assess as 
moderator variables. The val66met polymorphism in particular may be important for 
understanding age-related cognitive decline and degree of BDNF response to exercise 
(Erickson et al., 2012; Phillips, Baktir, Srivatsan, & Salehi, 2014).   
Despite these unanswered questions, the available evidence indicates that exercise 
should be considered as a successful strategy for enhancing BDNF activity.  Accordingly, 
use of exercise to enhance cognitive abilities and living skills has recently been 
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successful in dementia patients according to meta-analytic review (Forbes, Thiessen, 
Blake, Forbes, & Forbes, 2013), with preliminary promising evidence in Parkinson’s 
disease (Ahlskog, 2011), and schizophrenia (Oertel-Knochel et al., 2014).  The fact that 
exercise offers wide ranging physical health benefits (Alford, 2010) in addition to effects 
on mood (Asmundson et al., 2013; Josefsson et al., 2014; Stathopoulou et al., 2006) and 
cognition (Erickson et al., 2012; Smith et al., 2010) encourages the regular application of 
exercise as a particularly broad spectrum intervention.   
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Chapter 3. Feasibility and Efficacy of Exercise as an Augmentation Strategy to Brief 
Behavioral Activation Treatment 
 Major Depressive Disorder (MDD) affects one-quarter to one-third of US adults 
across the lifespan (Kessler et al., 2012).  It is the leading cause of disability for adults 
ages 15-44 (World Health Organization, 2004) and is estimated to cost employers over 
$36 billion per year in absenteeism and lost productivity (Kessler et al., 2006).  MDD 
also has been implicated as a cause or predictor of worse course for several medical 
conditions (Gillen et al., 2001; Peyrot & Rubin, 1997), including cardiovascular disease, 
hypertension, cancer, and chronic pain (Anderson et al., 2001). 
 Given the prevalence, disease burden, and medical conditions associated with 
MDD, there is a significant need for efficacious treatment for this condition.  Though 
efficacious psychosocial and pharmacological treatments exist, about 19-34% of 
depressed patients do not respond and only 29-46% of patients partially respond to either 
antidepressant treatment or cognitive behavioral therapy (CBT; Fava & Davidson, 1996).  
Additionally, the large-scale Sequenced Treatment Alternatives to Relieve Depression 
(STAR-D) trial has shown limited efficacy for combined or sequential treatment with 
antidepressants and CBT for patients failing to respond to initial interventions (Gaynes et 
al., 2008).  Therefore, there exists a need for other treatment options (Pigott et al., 2010), 
of which exercise offers a viable alternative. 
Several meta-analyses have documented the efficacy of exercise interventions in 
improving depression symptoms, including a recent meta-analysis of 23 randomized-
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controlled trials (RCTs) in which exercise demonstrated a large effect over non-active 
control conditions (Cooney et al., 2013; Kvam et al., 2016; Stathopoulou et al., 2006).  
Further, a meta-analysis of 6 RCTs found that exercise improved not only physical and 
psychological domains of depression but also enhanced overall quality of life (Schuch, 
Vancampfort, Rosenbaum, Richards, Ward, & Stubbs, 2016).   
A recent review identified multiple studies that together suggest strong efficacy 
for exercise in combination with antidepressant treatment (Mura et al., 2014).  However, 
there is a more limited research base examining exercise in combination with 
psychosocial treatments, though some research suggests that this combination strategy 
may be efficacious.  For example, Kruisdijk and colleagues (2012) found that aerobic 
exercise in combination with treatment as usual offered beneficial effects for MDD.  
Merom and colleagues (2008) demonstrated efficacy of exercise in combination with 
CBT for anxiety disorders in reducing depression, anxiety, and stress scores after 8-10 
weeks of treatment.  To my knowledge, the combined use of behavioral activation, 
specifically, and exercise has only been examined in one trial.  In this 6-month pilot trial 
consisting of 29 patients with comorbid MDD and Type 2 diabetes, behavioral activation 
plus exercise significantly lowered depression scores over time (Schneider et al., 2016).  
The current study represents only the second known study of a combination behavioral 
activation plus exercise augmentation targeting individuals with MDD and one of few 
studies examining the combination of exercise and an efficacious psychosocial treatment. 
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Behavioral activation (BA) is an empirically-supported treatment aimed at 
engaging patients in rewarding, adaptive activities and reducing involvement in behaviors 
maintaining depression symptoms (Dimidjian et al., 2006).  Meta-analyses have reported 
that behavioral activation enhances overall well-being (Mazzucchelli et al., 2010) and 
that activity scheduling, a primary component of BA, reduces depression symptoms with 
similar effect sizes to both cognitive therapy and antidepressant medication (Cuijpers et 
al., 2007).   
As approximately 75% of Americans do not engage in regular physical activity 
(Flegal et al., 2016), garnering motivation to exercise may be challenging.  BA, however, 
offers an ideal format for enhancing adherence to an exercise regimen.  The brief 
behavioral activation treatment for depression (BATD) format of BA asks patients to 
identify values and specific activities in several life areas, including mind, body, and 
spirituality, which offers a good fit for including exercise goals.  Subsequent activity 
scheduling then allows for planning of exercise sessions on specific days and times.  
During the activity scheduling component of BA, patients complete problem-solving 
strategies to enhance likelihood of completing their goals.   
The rationale for BA involves completing activities in the service of improving 
mood; prescribing exercise for mood fits with this model.  A recent study of individuals 
with serious mental illness in a partial hospital program found that an exercise for mood 
prescription led to increased exercise, especially for individuals who were already active, 
after only one session (Hearon et al., 2016).  Another study found that as patients 
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experience more satisfaction and progress towards their exercise goals, they may 
experience a feed-forward cycle in which they continue to exercise (Baldwin et al., 
2013).  This may apply to other goals set in BA as well. 
Cognitive Benefits of Exercise 
In addition to the beneficial effects of exercise on depressed mood and quality of 
life (Kvam et al., 2016; Schuch, Vancampfort, Rosenbaum, Richards, Ward, & Stubbs, 
2016), meta-analytic review indicates reliable improvements in cognition (attention and 
memory) with moderate-intensity exercise (McMorris & Hale, 2012).  Individual studies 
have identified specific benefits of exercise to cognition, particularly to hippocampal 
pathways.  For example, Griffin and colleagues (2011) found that acute aerobic exercise 
improved performance on a hippocampal-dependent learning task, a face-name matching 
task.  Erickson and colleagues (2011) extended this finding to a year-long exercise 
intervention for older adults with dementia.  Moderate-intensity aerobic exercise 
selectively increased hippocampal volume in the area where cell proliferation occurs.  
Thus, exercise was deemed an effective strategy for reversing hippocampal volume loss 
which often occurs in late adulthood. 
 All of these benefits are highly relevant to depression. Meta-analyses have 
identified an association between depression and cognitive deficits particularly in 
memory (episodic memory and working memory; McDermott & Ebmeier, 2009) and 
attention (Rock et al., 2013).  There is the potential for these deficits to attenuate 
adherence to BA interventions, as well as reduce the overall quality of life outcomes 
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experienced by patients.  Cognitive disruption is an important determinant of disability in 
depression that may not be well treated with pharmacotherapy or psychotherapy 
(Deckersbach et al., 2010; Wekking et al., 2012).  Hence, amelioration of these deficits 
has the potential for improving patient outcomes.   
Distress Tolerance Benefits of Exercise 
Distress intolerance (DI), the inability to tolerate distressing states or experiences, 
has been identified as a risk factor impacting engagement in health behaviors (Otto et al., 
2016) and is associated with higher depression and psychological distress (Williams et 
al., 2013).  Exercise interventions have been shown to lower DI scores as quickly as in a 
few weeks (Broman-Fulks & Storey, 2008; Smits et al., 2008) or even a single session 
(LeBouthillier & Asmundson, 2015).  A recent RCT found that in a sample of 136 
sedentary, daily smokers, those with high baseline anxiety sensitivity (a component of 
DI) receiving standard smoking cessation treatment plus CBT and exercise were more 
likely to remain abstinent than those in the control condition (Smits et al., 2016).   
Life stress and patients’ subsequent stress response may also be impacted by 
exercise; however, few studies have examined this effect in depressed patients.  In one 
study, an inverse relationship between exercise and affective symptoms of depression 
(e.g., depressed mood, anhedonia, fatigue, sleep disturbance, eating problems, feelings of 
guilt and worthlessness, suicidal ideation) was found following a performance-related 
social stress test (Booij et al., 2015).  Somatic symptoms, particularly heart rate during 
the social stress test, mediated this relationship. 
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The Current Study 
Given the few studies examining the benefit of exercise augmentation to behavior 
therapy as well as the paucity of literature on the effects of exercise for distress 
intolerance and stress in depressed patients, the current study was a pilot trial designed to 
identify efficacy of exercise as an augmentation strategy to BA with several key 
outcomes.  In the study design, a brief BA treatment (9 sessions) was combined with 
either exercise or a stretching control condition. The primary goal of this study was to 
establish the feasibility and acceptability of this combination treatment and to examine 
preliminary estimates of efficacy.  Efficacy was examined with traditional significance 
testing and by effect size estimation for the primary outcome measure of clinician-rated 
depressed mood, the Montgomery-Asberg Depression Rating Scale (MADRS), as well as 
the secondary outcome of the self-reported Beck Depression Inventory-II.  As depression 
interferes with quality of life and cognition, these outcomes were assessed as well.  
Finally, potential psychological moderators, distress intolerance and perceived stress, 
were evaluated. 
Methods 
Participants 
Depressed adults were recruited via internet and flyer advertisements in the 
community (recruiting depressed individuals interested in exercising) as well as from 
referrals from the Center for Anxiety and Related Disorders at Boston University.  
Interested participants were screened over the phone, and if preliminary eligibility 
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requirements were met, were scheduled for an in-person diagnostic and medical 
evaluation.  Prior to participation at the screening visit, participants were provided with a 
complete description of the study.  Inclusion criteria were the following: (1) males or 
females ages 18-65; (2) current principal diagnosis of major depressive disorder (MDD) 
or persistent depressive disorder (PDD) with a current major depressive episode (MDE) 
as determined by the Anxiety and Related Disorders Interview Schedule for DSM-5 
(ADIS-5; Brown & Barlow, 2014); and (3) sedentary (moderate-intensity exercise less 
than two days per week for at least 40 minutes each time for at least three months).  
Participants were not required to evidence treatment-refractory depression (i.e., failing 
trials of antidepressant treatment). 
Psychiatric exclusion criteria included current or past psychotic disorders of any 
type, bipolar disorder (1, II, or unspecified), schizophrenia or schizoaffective disorder, 
anorexia, bulimia, alcohol or drug dependence within the last three months, or currently 
suicidal or at high suicide risk as evaluated by the Columbia Suicide Severity Rating 
Scale (C-SSRS; Posner, Oquendo, Gould, Stanley, & Davies, 2007; endorsing yes to 
items 4 or 5) and Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) 
suicide item (≥ score of 2). 
 Medical exclusion criteria included risk for exercise participation according to 
Physical Activity Readiness Questionnaire (PAR-Q) in accordance with guidelines set 
forth by the American College of Sports Medicine (ACSM) as well as assessment by the 
study physician.  Physical conditions deemed a risk for study participation included heart 
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conditions, diabetes, asthma or another lung disease, bone/joint problems, or seizure 
disorder.  Other exclusion criteria included individuals who have participated in CBT for 
a mood disorder within three months of baseline, those simultaneously participating in 
another psychosocial treatment (other than supportive therapy) or those taking 
psychotrophic medications (unless at eight weeks of stable dosage) as well as women 
who were currently pregnant, planned to be pregnant in the next year, or currently 
breastfeeding. 
 Participants were enrolled in the study between July 2014 and April 2016 and all 
follow-up assessments were completed by August 2016.  All study procedures were 
approved by the Institutional Review Board. A total of 38 individuals were enrolled in 
the study and 34 met inclusion criteria.  Two individuals discontinued participation prior 
to the baseline study visit and one discontinued participation after the baseline visit but 
baseline data was obtained and analyzed in the intent-to-treat analysis. Thirty-one 
individuals were randomized to either the exercise (n = 15) or stretching (n = 16) 
augmentation, with randomization occurring immediately prior to participation in Week 1 
of treatment. A total of 20 participants completed the entire study including the 1-month 
follow-up assessment.  Figure 6 summarizes participant flow throughout the study. 
Assessments 
Assessments were completed at baseline, Week 4, Week 8, Week 12 (treatment 
endpoint), and Week 16 (1-month follow-up).  Additionally, the BDI-II and the Physical 
Activity Recall questionnaire (PAR) were completed weekly.  Assessments completed at 
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the screening visit included the ADIS-5 (Brown & Barlow, 2014), the Physical Activity 
Readiness Questionnaire (PAR-Q) and the C-SSRS (Posner et al., 2007).  The ADIS-5 
was used to assess psychiatric diagnoses and the C-SSRS, a standardized measure of 
current and past self-injurious behavior, suicidal intent, and suicidal behaviors, was used 
to assess for individuals who were currently suicidal or at high suicide risk.  The PAR-Q, 
which assesses for different medical conditions that may impact the ability to exercise, 
was used to assess medical risk for physical activity completion. 
 The primary outcome measure for this trial was the Montgomery-Asberg 
Depression Rating Scale (MADRS; Montgomery & Asberg, 1979), which is a 10-item, 
clinician-rated measure of depression severity.  The MADRS has been shown to have 
strong validity and inter-rater reliability in several studies (Davidson, Turnbull, 
Strickland, Miller, & Graves, 1986; Montgomery & Asberg, 1979) and the CGI has been 
used as a marker of treatment response in several studies of depressed patients (Riedel et 
al., 2010; Sonawalla et al., 1999; Suppes et al., 2016).  All independent evaluators (who 
completed MADRS and CGI (Guy, 1976) ratings) were trained by the first author until 
reliability was established and were blind to treatment augmentation condition. 
 Secondary outcome measures included self-reported measures of depression 
symptoms and severity, disability and work performance, overall functioning and 
improvement over the course of treatment, distress intolerance, perceived stress, and 
outcome expectancy.  Depression was measured by the BDI-II (Beck et al., 1996) and 
disability and work functioning was measured by the Work and Social Adjustment Scale 
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(WSAS; Mundt, Marks, Shear, & Greist, 2002).  The Quality of Life Enjoyment and 
Satisfaction Questionnaire (Q-LES-Q; Endicott, Nee, Harrison, & Blumenthal, 1993) and 
the Clinical Global Impressions Improvement/Severity rating (CGI; Guy, 1976) were 
used as measures of overall functioning and improvement over the course of treatment.  
Distress intolerance was measured using the Distress Intolerance Index (DII; McHugh & 
Otto, 2012), which assesses the self-reported inability to tolerate stressful states, and 
perceived stress was assessed with the Perceived Stress Scale (PSS; Cohen, 1988).  The 
Credibility-Expectations Questionnaire (CEQ; Devilly & Borkovec, 2000) was 
administered following the introduction and completion of the first treatment session and 
focused on credibility and expected outcome of the exercise or stretching augmentation 
strategy.   
 Physical activity was assessed via the 7-Day Physical Activity Recall (PAR; Blair 
et al., 1985), an interviewer-administered measure of physical activity behavior which 
has been shown to be sensitive to change in studies of moderate-intensity activity (Dunn, 
Andersen, & Jakicic, 1998).  Metabolic equivalents (METs) were calculated for both 
vigorous- and moderate-intensity physical activity.  Patients also completed maximal 
exercise testing at baseline, Week 4, Week 8, and Week 16 to assess changes in objective 
physical ability (e.g., heart rate) and subjective ratings of distress induced by physical 
activity (e.g., perceived ratings of exertion).  Maximal exercise testing was conducted via 
a Balke protocol that consisted of 2-min stages beginning at 2.4 mph and 0% grade. 
Measurement of functional capacity expressed as heart rate and treadmill duration was 
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used to determine the differential effect of the intervention on fitness. During the exercise 
testing, participants were asked to rate their perceived exertion (using the Borg Rating of 
Perceived Exertion Scale) and overall distress at 2-minute intervals.    
 The neuropsychological faculties of attention and memory were evaluated by the 
Continuous Performance Test-Identical Pairs (CPT-IP; Cornblatt, Risch, Faris, Friedman, 
& Erlenmeyer-Kimling, 1988) and the Logical Memory, Immediate Recall subtest of the 
Wechsler Memory Scale-IV (WMS-IV), respectively.  The Logical Memory test was 
chosen to represent an analogue to the learning of verbal psychoeducational information 
in clinical settings.  Both tests were administered at baseline, Week 12, and Week 16.  
Interventions 
Participants were randomized to receive either an exercise or stretching 
augmentation strategy in addition to nine sessions of brief behavioral activation 
treatment.  Randomization assignments were generated from an online random number 
generator and were generated prior to allocating participants.  All independent evaluators 
were blind to randomization assignment.   
 Behavioral activation. All participants received a standard behavioral activation 
treatment based on a modified version of the manualized treatment by Lejuez and 
colleagues (2011). Treatment was delivered in 60-minute weekly individual sessions over 
a 6-week period followed by 3 biweekly booster sessions. Session 1 focused primarily on 
psychoeducation about depression with an introduction to activity monitoring.  Session 2 
introduced the identification of life areas, values, and activities and Session 3 ranked a 
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selection of these activities in order of difficulty.  Session 4 introduced the concept of 
activity scheduling which was practiced throughout the rest of the treatment.  Session 5 
discussed the role of social support in aiding with completion of valued activities and 
Session 6 first introduced the concept of preparing for the end of treatment.  The 
biweekly booster sessions reviewed each of these concepts and continued the problem-
solving process for any difficulties the patient still encountered.  Homework compliance 
was rated at weeks 2-6, 8, 10, and 12 based on the coding system developed by Busch 
and colleagues (2010).  
 Exercise augmentation. Participants randomized to the exercise augmentation 
condition received this intervention immediately following each of the first six weekly 
BA sessions.  Each exercise session comprised 30 minutes of providing rationale for the 
program, introducing new motivation enhancement strategies, and/or reviewing the 
previous week’s progress. During the three booster sessions, the exercise check-ins were 
incorporated into the behavioral monitoring section of BA treatment. As part of the 
intervention, participants were asked to perform a total of 150 minutes of moderate-
intensity aerobic exercise per week. The study therapist aided all participants in initiating 
and planning their at-home program of exercise, working together to develop a training 
progression schedule (e.g., frequency will be 3 times a week, with varying intensity and 
duration) that allowed the participants to comfortably participate in the intervention. 
Procedures to aid the enjoyment of exercise sessions (attentional focus exercises, use of 
music or audiobooks, etc.) as outlined in Otto & Smits (2011), were also provided.  
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 Stretching augmentation. Individuals randomized to the stretching augmentation 
condition were provided the intervention following each of the first six weekly BA 
sessions.  These sessions included 30 minutes of providing rationale for the stretching 
program, introducing new motivation enhancement strategies, and/or reviewing the 
previous week’s progress to match the interventions received by the exercise group. As 
part of the intervention, participants were asked to perform 150 minutes of stretching 
each week.  To match the guidance provided by the Otto and Smits (2011) book for 
exercise, participants in this condition were provided with a 50-minute DVD of stretching 
exercises and worked with the study therapist to plan their at-home stretching regimen. 
Participants were encouraged to engage in light stretching and flexibility exercises, which 
may include certain yoga poses.  However, participants were discouraged from 
participating in intense forms of yoga (e.g., bikram) as this would bound on more 
moderate-intensity levels of physical activity.  
Statistical analysis 
Power calculations were derived from a meta-analysis (Stathopoulou et al., 2006) 
indicating a large effect size (d = 1.42) favoring exercise over non-active control 
conditions.  Given this study included two groups receiving active treatment, I chose a 
more conservative effect size (d = 0.40).  A sample size of 32 patients provided adequate 
power (80%) to detect an effect of that size for an outcome measure with 5 observations 
(i.e., 5 administrations of the MADRS, alpha= 0.05) using a repeated measures ANOVA. 
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A repeated measures design allows for an increased sensitivity to detect differences 
between groups.  
 Demographic and clinical differences between conditions at baseline were 
assessed via χ2 analyses or t-tests.  Comparison of dropout rates by treatment group was 
performed using a χ2 test.  Intent-to-treat analyses were conducted using a mixed-effects 
linear regression model with likelihood-based estimation methods where follow-up 
assessments were entered as repeated dependent variables.  Treatment group and time as 
well as their interaction were included as independent variables.  Cross-time correlations 
were freely estimated using an unstructured variance-covariance matrix.  All analyses 
were conducted using SPSS Version 24.0. 
Results 
Participant baseline characteristics 
The intent-to-treat sample was 78% female with a mean age of 33.7 (±13.4).   
Primary diagnosis was MDD for 66% of the sample and PDD for the other 34%.  Eight 
individuals had co-principal diagnoses of either GAD (n = 5; 16%) or social anxiety 
disorder (n = 3; 9%).  Several participants were assigned secondary diagnoses, with the 
most prevalent being social anxiety disorder (47%) and GAD (31%).  The average 
number of diagnoses for an individual participant was 2.6 ± 1.2.  Eighteen participants 
(56%) were taking psychiatric medications at baseline (44% of total sample taking an 
antidepressant; 9% of total sample taking a benzodiazepine).  At baseline participants 
were in the moderate range of depression according to the MADRS (25.9 ± 7.9) and BDI-
 
 
 
 
 49 
II (M = 27.0 ± 10.2) and were reporting significant impairment in overall functioning 
(WSAS: M = 24.4 ± 7.6) and quality of life (Q-LES-Q: M = 39.5 ± 7.9).  Chi-square and 
t-tests did not reveal significant differences between groups on demographic or clinical 
characteristics (all p > 0.09).  For full description of study baseline characteristics, see 
Table 1. 
Intervention credibility 
Overall, patients reported high levels of both credibility (M = 27.1 ± 4.7, range 
from 18 to 35; questionnaire range from 4 to 36) and expectancy (M = 12.6 ± 3.1, range 6 
to 18; questionnaire range from 2 to 18) for the effects of the randomized treatment on 
their depression symptoms.  There were no differences between the exercise and 
stretching groups on ratings of credibility of the intervention as assessed by the CEQ 
(t(29) = -0.79, p = 0.44, d = 0.29).   
Acceptability, treatment completion, and dropout 
To determine acceptability of study interventions, I examined willingness to 
engage in the trial.  These rates were determined by percentage of qualified individuals 
based on the phone screen who chose to sign consent and participate in the study.  Two 
participants (5%) who attended the screening visit declined to participate prior to 
consenting.  Another three participants (7.5%) discontinued participation following 
screening and/or baseline study visits.  A total of 77.5% of participants who attended the 
in-person screening visit chose to enroll in the study through randomization. 
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Overall, participants completed an average of 6.9 (±3) sessions.  As shown in 
Figure 1, six participants (4 during treatment and 2 during follow-up, 40% total) in the 
exercise condition and four (3 during treatment and 1 during follow-up, 25% total) in the 
stretching condition dropped out during the study.  These dropout rates were not 
significantly different from each other (χ2(1) = 0.78, p = 0.37, d = 0.32).  Neither baseline 
credibility (Exp(B) = 0.93, p = 0.42) nor expectancy (Exp(B) = 0.85, p = 0.22) ratings 
significantly predicted dropouts.  Overall, 68% of sample completed the entire study 
including 1-month follow-up. 
Homework completion 
On average, participants had a homework completion rate of 77.1% (± 15.8).  
Homework completion did not differ by group (t(25) = 1.15, p = 0.26).  There was a 
significant inverse association between percentage of homework completed and difficulty 
level of homework (r = -0.22, p = 0.002). 
Physical activity and stretching outcomes 
Evaluation of the effect of the randomized intervention conditions on exercise 
based on the PAR revealed no significant differences between the groups on exercise 
completion over time (group by time interaction: F(4, 21) = 0.73, p = 0.58, d = 0.30); 
group main effect: (F(1, 22) = 0.78, p = 0.39, d = 0.31).  See Figure 7 for more 
information.  A significant effect for time indicated that participants, regardless of 
randomized treatment group, performed more METs of combined vigorous- and 
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moderate-intensity physical activity over the course of the study at a level approaching a 
large effect size (F(4, 21) = 4.6, p = 0.008, d = 0.76).  
Similar effects were found when examining vigorous intensity exercise alone.  
There was no main effect of group (F(1, 24) = 0.13, p = 0.72, d = 0.13) or a group by 
time interaction (F(4, 25) = 0.99, p = 0.43, d = 0.35); however, there was a significant 
effect of time (F(4, 25) = 2.72, p = 0.05, d = 0.58) in which participants participated in 
more vigorous intensity exercise over time, regardless of randomization condition. 
In contrast to the exercise data, a significant group by time interaction (F(4, 23) = 
8.10, p < 0.001, d = 1.01) was found for the stretching measure, whereby the stretching 
group completed more stretching over time than the exercise group. 
Treatment outcome overview 
As detailed in Table 2, participants significantly improved on all symptom (i.e., 
MADRS, BDI-II), quality of life (i.e., Q-LES-Q, WSAS), and psychological (i.e., DII, 
PSS) measures over time.  Participants also significantly improved on the cognitive 
measures of immediate recall, delayed recall, and recognition over time.  The only 
measure for which participants did not evidence improvement over time was the measure 
of attention, CPT-IP.  
 Group by time interaction effects occurred for the two psychological measures —
the DII and PSS, whereby those in the exercise group evidenced greater improvement 
over time.  All effects will be described in greater detail in the sections below. 
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Primary outcome.  In a mixed-effects linear regression model including 
condition, time, and time by condition interaction, there was a significant main effect of 
time for all participants (F(4, 21) = 11.3, p < 0.001, d = 1.19), at a large effect size, for 
the primary outcome of the MADRS (see Figure 8).  There was no significant main effect 
of group (F(1, 29) = 0.88, p = 0.36, d = 0.33) or group by time interaction effect (F(4, 21) 
= 0.99, p = 0.44, d = 0.35).  The small to moderate effect sizes indicated non-significant 
trends toward more improvement in the exercise group versus the stretching group over 
time.  
 Secondary clinical outcomes.  When examining a mixed-effects linear regression 
including condition, time, and time by condition interaction, there was no significant 
group by time interaction effect or main effect of group for the BDI-II, Q-LES-Q, and 
WSAS (see Figures 9-11).  However, patients significantly improved in all of these 
measures over time (BDI-II: F(4, 18) = 10.77, p < 0.001, d = 1.16; Q-LES-Q: F(4, 20) = 
8.9, p < 0.001, d = 1.06; WSAS: F(4, 20) = 6.1, p = 0.004, d = 0.87), with effect sizes in 
the large range.   
Based on cutoff of BDI-II < 10 (used in Chalder et al., 2012), 40% of the total 
sample (n =12) met criteria for being in recovery from depression symptoms at 1-month 
follow-up.  Of the 19 trial completers, 11 (55%) met criteria for being in recovery at 1-
month follow-up.  Fisher Exact Tests indicated no significant differences in rates of 
recovery by treatment group (p = 0.71). 
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For the DII and PSS, there were significant group by time interactions on the 
order of medium to large effect sizes (F(4, 22) = 3.9, p = 0.016, d = 0.70) and (F(4, 21) = 
2.8, p = 0.049, d = 0.60), respectively, whereby those in the exercise group improved 
more in DII and PSS scores over time (See Figures 12 and 13).  Additionally, for all 
participants, DII (F(4, 22) = 4.9, p = 0.008, d = 0.78) and PSS (F(4, 21) = 8.8, p = 0.001, 
d = 1.05) significantly improved over time. There were no significant main effects of 
group for either the DII or PSS. 
I also examined the same effects substituting total amount of moderate and 
vigorous intensity exercise (as a continuous variable) for randomization condition.  For 
the DII, amount of exercise (F(1, 74) = 0.60, p = 0.44, d = 0.27), time (F(4, 25) = 1.66, p 
= 0.19, d = 0.46), and their interaction (F(4, 32) = 1.79, p = 0.15, d = 0.47) were not 
significant; however, effect sizes were in the small to moderate range.  For the PSS, both 
time (F(4, 28) = 5.90, p = 0.001, d = 0.86) and the interaction between time and exercise 
(F(4, 24) = 5.00, p = 0.004, d = 0.79) exhibited significant, large effects.  Additionally, 
though total amount of exercise was not significant (F(1, 42) = 2.28, p = 0.14, d = 0.53), 
it demonstrated a moderate effect size. 
 Cognitive outcomes.  Results indicated a significant main effect of time for three 
components of the Logical Memory cognitive measure: WMS-IV Logical Memory I, 
immediate recall (F(2, 15) = 6.0, p = 0.01, d = 0.87); WMS-IV Logical Memory II, 
delayed recall (F(2, 16) = 19.8, p < 0.001, d = 1.56); WMS-IV Logical Memory 
recognition subtest (F(2, 20) = 8.2, p = 0.003, d = 1.01), all on the order of large effect 
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sizes.  On the WMS-IV Logical Memory recognition subtest, there was a trending 
difference of a group main effect indicating better performance by those in the exercise 
condition (F(1, 30) = 3.3, p = 0.078, d = 0.65) at the level of a medium effect size.  For 
the Logical Memory I and II subtests, there were no significant main effects of group or 
group by time interactions.  
 The average scores for the three conditions of the CPT-IP did not reveal any 
significant main effects of group (F(1, 17) = 0.25, p = 0.62, d = 0.18), time (F(2, 6) = 1.1, 
p = 0.39, d = 0.37), or significant interaction effects (F(2, 6) = 2.4, p = 0.17, d = 0.55). 
Association between exercise and mood outcomes. Because both of the 
randomized intervention groups significantly improved in exercise levels, I examined the 
association between exercise and treatment outcome (ignoring group assignment). 
Exercise was linked to BDI-II outcomes.  Specifically, a mixed effects model of the 
effect METs of vigorous- and moderate-intensity exercise, time, and their interaction on 
mood outcomes (i.e., BDI-II, MADRS), revealed significant main effects of time (F(4, 
25) = 4.43, p = 0.008, d = 0.75) and METS of exercise (F(1, 65) = 5.52, p = 0.02, d = 
0.83) as well as a significant interaction effect (F(4, 28) = 4.50, p = 0.006, d = 0.75) for 
the BDI-II.  These effects indicated that those who exercised more received sharper 
declines in depression symptoms as assessed by the BDI-II over time.  There was no 
main effect of METs of exercise or interaction effect on the MADRS, however.  
Association between exercise and cognitive outcomes.  Similarly to analyses 
above, I also examined the association between exercise and cognitive outcomes (i.e., 
 
 
 
 
 55 
attention and memory) ignoring randomization.  In a mixed effects model including 
METs of vigorous- and moderate-intensity exercise, time, and their interaction on 
attention, there were no significant main effects of time (F(2, 16) = 0.28, p = 0.76, d = 
0.19) or exercise (F(1, 33) = 0.59, p = 0.45, d = 0.27) nor was there a significant 
interaction effect (F(2, 18) = 0.065, p – 0.94, d = 0.09). 
When conducting the same analysis with immediate recall, delayed recall, and 
recognition tests of memory, there were no significant main effects of exercise 
(immediate recall: F(1, 36) = 0.076, p = 0.78, d = 0.10; delayed recall: F(1, 30) = 1.74, p 
= 0.20, d = 0.47; recognition: F(1, 21) = 0.002, p = 0.97, d = 0.02) or significant 
interactions between exercise and time (immediate recall: F(2, 22) = 0.21, p = 0.81, d = 
0.16; delayed recall: F(2, 18) = 0.15, d = 0.14; recognition: F(2, 18) = 1.76, p = 0.20, d = 
0.47).  However, there was a significant main effect of time for both the delayed (F(2, 
19) = 9.14, p = 0.002, d = 1.07) and recognition (F(2, 18) = 6.42, p = 0.008, d = 0.90) 
memory subtests, but not for the immediate recall subtest (F(2, 16) = 1.98, p = 0.17, d = 
0.50). 
Discussion 
 This study involved the examination of the feasibility, acceptability, and efficacy 
of a brief BA treatment with an exercise augmentation intervention for sedentary 
individuals with MDD.  Regarding feasibility, results indicated that the intervention 
yielded a completion rate of 68%, similar to other studies of both exercise (e.g., 75% 
compliance, Kai et al., 2016; 53% average attendance at supervised exercise sessions, 
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Smits, Powers, et al., 2016; 67% completion rate for 12 weeks of exercise among 
depressed participants, Toups et al., 2011; 70% completion rate of at least 5 exercise 
sessions: Chalder et al., 2012) and BA (e.g., 76% completion rate, Moshier & Otto, 2017; 
78% completion of 8-10 sessions, Collado et al., 2016; 81% completion rate, Hopko et 
al., 2011)  interventions.  As 77.5% of participants who attended the in-person screening 
chose to enroll in the study through randomization, participants demonstrated 
acceptability of the trial as a whole.  Only two individuals were no longer interested in 
study participation at the in-person screening visit, which was the same for a comparable 
pilot trial of combination exercise and BA for depressed women with Type 2 diabetes 
(Schneider et al., 2016). Additionally, participants found both the exercise and stretching 
augmentation strategies to be credible.  However, the randomized treatment failed to lead 
to differential levels of exercise between groups. In fact, regardless of randomized 
condition, participants exercised more over time.   
 Despite lack of differences between groups, results indicated that participants 
demonstrated lower clinician-rated and self-reported depression as the trial progressed.  
Additionally, on average, participants improved in quality of life and exhibited lower 
levels of disability throughout the trial.  Performance on measures of immediate and 
delayed recall improved; however, there was no significant improvement in attention 
over time.  For both DI and perceived stress, significant group by time interactions 
emerged indicating that those assigned to the exercise group exhibited sharper declines in 
DI and perceived stress over time than those in the stretching group.  When substituting 
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randomization condition with total exercise, similar significant results were demonstrated 
for perceived stress with a large interaction between exercise and time (d = 0.79).  A non-
significant, but moderate interaction effect (d = 0.47) was present for DI.  
 Because the difference in exercise levels between randomized groups was not 
significant, it can be expected that the design would not produce differential group effects 
on depression and other outcomes.  However, when examining the interaction 
substituting randomization condition with total amount of exercise completed, a different 
picture emerged for self-reported depression.  Participants who completed more exercise 
demonstrated sharper declines in depression symptoms over time, regardless of treatment 
randomization.    
Therefore, a likely reason for the lack of differences in depression outcomes 
between exercise and stretching groups may be due to the amount of moderate-intensity 
exercise completed by the stretching group.  Though previous trials have demonstrated 
low rates of exercise versus usual care conditions (Chalder et al., 2012), this trial did not.  
Participants overall, regardless of group assignment, completed more exercise over time.  
This may raise questions as to the potential power of BA offering a context in which not 
only to increase overall activity but also exercise.  Thus, an additional exercise 
prescription may not be necessary when a patient is completing BA.  BA offers an ideal 
format to schedule specific exercise and other activities that may inadvertently lead to 
more exercise.  For example, when patients schedule time to visit a friend, this may 
include walking to the friend’s house, offering a chance for physical activity that was not 
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previously present.  Moreover, the focus on physicality in the exercise condition may 
have interacted with the activity focus of BA, leading to increases in exercise.  This is not 
typical for stretching control conditions (e.g., Dunn, Trivedi, Kampert, Clark, & 
Chambliss, 2005; Erickson et al., 2011), again implicating BA as a potential exercise-
enhancing treatment. 
 These results add to the growing literature on the efficacy of brief behavioral 
activation for the treatment of depression (BATD).   In early trials, BATD was shown to 
be effective in improving depression symptoms for psychiatric inpatients over the course 
of only two weeks with three 20-minute sessions per week (Hopko, Lejuez, et al., 2003).  
BATD has demonstrated efficacy with outpatients as well.  For example, 8 sessions of 
BATD significantly improved depression, anxiety, and quality of life outcomes both at 
post-treatment and 12-month follow-up in a large RCT of depressed breast cancer 
patients (Hopko et al., 2011).  The eight-session format of BATD has also successfully 
been implemented in military personnel and veterans via videoconferencing with strong 
effect sizes for improvements in depression over time (Luxton et al., 2016), and the 10-
week version was found to reduce depression symptoms and lead to greater MDD 
remission when adapted for use in a Spanish-speaking Latino population (Collado, 
Calderon, MacPherson, & Lejuez, 2016).  Even as few as four sessions of BATD has 
been shown to decrease depression and rumination symptoms (Moshier & Otto, 2017).  
The current study indicates that a format of six weekly sessions of BATD, plus 3 
biweekly booster sessions is effective in improving depression and quality of life in 
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sedentary, depressed adults, a population that may have more difficulty engaging in 
rewarding activities due to their baseline sedentary lifestyles. 
 As both the BA and exercise interventions targeted depression, it may have 
reduced ability to identify specific effects of the exercise augmentation on depression 
outcomes.  However, results of this trial demonstrated moderate to large effects of the 
interaction between randomization condition/total exercise and time for both DI and 
perceived stress.  Therefore, exercise may offer unique benefits to improvements in both 
DI and perceived stress.  Indeed, research suggests that exercise alone in as little as two 
weeks (Smits et al., 2008) or even one session (LeBouthillier & Asmundson, 2015) can 
reduce anxiety sensitivity (AS), a component of DI, on the order of a large effect size.  
Given that exercise produces similar sensations to the physical sensations feared by those 
with high AS, it may serve as an interoceptive exposure.  Sabourin and colleagues (2015) 
specifically utilized exercise in this fashion and found that cognitive (i.e., catastrophic 
thoughts) and affective (i.e., feelings of anxiety) reactions were minimized over time in 
those high in AS.  As similar physical sensations are part of the fight or flight stress 
response, exercise may have a comparable effect on perceived stress.  For example, one 
study showed that a single bout of exercise attenuated blood pressure and heart rate 
responses to acute stressors (Rejeski et al., 1992).  Additionally, programmed exercise 
has been shown to decrease stress response to a computer simulated fire scene for 
firefighters (Throne et al., 2000). 
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This study is not without limitations.  The small sample size limited power to 
examine efficacy and moderation effects.  However, strong effects for improvement in 
several key variables (i.e., depression, quality of life, perceived stress, DI, memory) were 
found over time.  Additionally, there was a moderate rate of dropout from the study, with 
32% of the sample dropping out before completing the 12-week intervention plus 1-
month follow-up assessment.  Also, as noted, the choice to include an active control 
condition (i.e., stretching) in combination with BA may have contributed to lack of 
differences between groups.  At least one previous study found significant differences in 
depression symptoms between exercise and stretching groups (Dunn et al., 2005), but 
some found similar non-significant effects similar to those in the current study (Foley et 
al., 2008; Krogh, Videbech, Thomsen, Gluud, & Nordentoft, 2012).  For the current 
study, the context of BA may have encouraged greater exercise in the exercise as well as 
the stretching groups.   In addition to reduced sample size, there is a possibility of sample 
selection bias as individuals choosing to enroll in an advertised “exercise intervention” 
may have been more likely to engage in this activity thus also contributing to lack of 
differential results.  Additionally, the varied nature of the exercises and stretching chosen 
by participants may have contributed to differential effects on depression symptoms.  For 
example, those who chose more pleasant exercises may have received more benefits, as 
research has shown that individuals who enjoy exercise more maintain exercise programs 
(Ekkekakis, Parfitt, & Petruzzello, 2011).  
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 Given my findings indicating an association between BA and increased exercise, I 
recommend that future research examine the extent to which such increases may explain 
some of the efficacy of BA.   Accordingly, I recommend that studies utilizing BA as an 
intervention should assess exercise completion, using measures such as the 7 Day 
Physical Activity Recall (used in this study) or the self-reported International Physical 
Activity Questionnaire (Craig, Marshall, Sjöström, et al., 2003).  Future research may 
also focus on individuals with high DI or perceived stress to identify if there are benefits 
of exercise augmentation to BA in this subgroup of individuals.  Finally, future research 
should aim to build in other possible predictor or moderating factors, such as other 
cognitive tests or measures of avoidance, social anxiety, or social support that may 
impact outcomes. 
Conclusions 
 This study adds to the growing literature of the efficacy of brief behavioral 
activation for improvement of depression symptoms and overall quality of life.  In just 9 
sessions offered over the course of 12 weeks, on average patients improved significantly 
in their depression symptoms with 40% of the sample achieving complete remission.  
Though exercise plus BA did not result in differential effects in comparison to stretching 
plus BA, BA may be a useful strategy through which to encourage engagement in 
moderate-intensity activity.   
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Chapter 4.  Assessing BDNF as a Mediator of the Effects of Exercise on Depression  
 Brain-derived neurotrophic factor (BDNF) is a protein largely found in certain 
brain regions, such as the hippocampus, cerebral cortex, hypothalamus, and cerebellum, 
as well as in the peripheral nervous system.  BDNF plays a large role in neuronal growth 
and differentiation as well as reducing neuro-degeneration and increasing neuroplasticity.  
Given its role in neuronal growth, particularly in the hippocampus, studies have shown 
that decreased levels of BDNF are associated with impairments in memory, primarily 
memory consolidation, storage, and long-term memory (Cirulli et al., 2004; Roig et al., 
2013).   
 As BDNF and exercise have similar effects on improving cognition (McMorris & 
Hale, 2012; Smith et al., 2010), studies have suggested that BDNF may be the pathway 
by which exercise exerts its effects (Erickson et al., 2012).  A recent meta-analysis aimed 
to explicate the first component of this pathway, the effect of exercise on BDNF levels 
(Szuhany, Bugatti, & Otto, 2015; detailed in Chapter 2), both after a single bout of 
exercise and after a program of regular exercise.  Results indicated a moderate effect of 
an acute bout of exercise on an increase in pre- to post-exercise BDNF levels, which was 
replicated in a more recent meta-analysis of 55 studies of healthy adults (Dinoff, 
Herrmann, Swardfager, & Lanctot, 2017).  This pre- to post-exercise BDNF increase was 
intensified following a program of regular exercise.  Finally, resting BDNF levels also 
increased following a program of regular exercise, but on the order of a small effect size.  
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Results from this study suggest reliable BDNF increases following both acute and regular 
exercise.   
 However, few of the studies in the meta-analysis included participants with 
mental health conditions, and only three included individuals with depression 
(Gustafsson et al., 2009; Laske et al., 2010; Toups et al., 2011).  Within these three 
studies, conflicting results of the effect of BDNF change on depression exist; some 
suggest BDNF increases in depressed patients as depression improves (Laske et al., 2010) 
and some suggest BDNF is not a factor in depression changes (Toups et al., 2011). 
Yet, overall, research has implicated BDNF in pathways affecting depression.  
For example, studies have indicated that depressed patients show lower resting levels of 
serum and plasma BDNF than healthy controls (Bocchio-Chiavetto et al., 2010; Brunoni 
et al., 2008; Lee et al., 2007).  Additionally, meta-analyses and reviews (Russo-Neustadt 
& Chen, 2005; Sen et al., 2008a) and subsequent individual studies (Piccinni et al., 2008) 
have shown that antidepressant treatment significantly increases BDNF levels from pre- 
to post-treatment in depressed patients, though the relative degree of increase depends on 
the specific antidepressant (Zhou et al., 2017).    
The current study was designed to evaluate the change in BDNF activity for 
exercise in depressed patients and to examine the link between these changes and 
treatment outcome.  Specifically, this study examined the effects of a program of regular 
exercise in combination with a psychosocial treatment on depression symptoms, with 
BDNF as a potential mediator of these effects.  In accordance with results from the meta-
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analysis, I hypothesized that resting BDNF levels would increase in depressed individuals 
completing a program of regular exercise.  Additionally, I hypothesized that the pre- to 
post-increase in BDNF would intensify following a program of regular exercise.  Finally, 
I hypothesized that the increases in resting and pre- to post-exercise BDNF levels would 
be associated with the degree of improvement in depression symptoms and cognitive 
performance.  
Methods 
Participants 
Participants were sedentary adults ages 18-65 with a principal diagnosis of either 
major depressive disorder (MDD) or persistent depressive disorder (PDD) with a current 
major depressive episode.  Screening procedures and extended psychiatric and medical 
inclusion and exclusion criteria are presented in Chapter 3.   
 Participants included in this study were individuals from whom blood samples 
were able to be taken both pre- and post-exercise.  A total of 29 participants were able to 
provide at least 1 blood sample.  Three individuals were excluded due to inability to find 
a vein to draw blood.  Of these 29 participants, a total of 15 provided samples pre- and 
post-exercise across all four time points (baseline, Week 4, Week 8, Week 16) of the 
study.  Other participants dropped out prior to the completion of the study (n = 10) or 
were unable to provide a sample due to inability to find a vein on a particular visit (n = 
4).  All 29 participants were included in intent-to-treat analyses.  Of these 29 participants, 
14 were randomized to the exercise group and 15 to the stretching group. 
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Assessments 
Administration of the exercise test and collection of BDNF samples were 
completed at baseline, Week 4, Week 8, and at follow-up (Week 16).  Both clinician-
rated and self-report measures of depression as well as quality of life measures were 
collected at these time points as well.   
 Participants completed a maximal exercise test using a Balke protocol consisting 
of 2-min stages in which speed and grade were increased over time.  During this test, 
heart rate and ratings of perceived exertion (using the Borg Rating of Perceived Exertion 
Scale) were collected at the end of each stage.  Total time to exhaustion was also 
collected. 
BDNF was collected in conjunction with the maximal exercise tests at baseline, 
Week 4, Week 8, and Week 16 with sample collection occurring immediately prior to 
completion of the exercise test and immediately following completion of the exercise test 
to test both resting serum BDNF and to assess potential increases in BDNF activity 
following acute exercise.  After collection of blood samples, the red top test tube was 
allowed to clot for 25 ± 5 minutes at room temperature before being centrifuged at 3000 
RPM for 15 minutes. The resulting serum was pipetted into 5 microtubules and stored in 
a -80 degree freezer at Boston University.  Results were batch processed at the Albert 
Einstein School of Medicine/Montefiore Medical Center using ELISA assay kits from 
R&D Systems.  All serum BDNF results are in units of ng/ml. 
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Clinician ratings of depression were made using the Montgomery-Asberg 
Depression Rating Scale (MADRS; Montgomery & Asberg, 1979).  Self-report of 
depression was measured via the Beck Depression Inventory-II (BDI-II; Beck et al., 
1996).   
Intervention 
The interventions are described in greater detail in Chapter 3.  In short, 
participants were randomized to complete either a brief behavioral activation treatment (9 
sessions over the course of 12 weeks) plus an adjunctive exercise intervention or an 
adjunctive stretching intervention.  Exercise and stretching interventions included 
motivational strategies to enhance initiating and maintaining exercise/stretching regimens 
and planning at-home exercise/stretching with a goal of completion of 150 minutes of 
exercise/stretching per week. 
Data analysis 
Analyses were conducted using a mixed-effects linear regression model with 
likelihood-based estimation methods where follow-up assessments were entered as 
repeated dependent variables.  Treatment group and time as well as their interaction were 
included as independent variables.  Cross-time correlations were freely estimated using 
an unstructured variance-covariance matrix.  Models were analyzed with both resting 
BDNF levels (collected prior to the exercise test) and change in BDNF levels from pre- 
to post-exercise as dependent variables.  All analyses were conducted using SPSS 
Version 24.0. 
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Results 
Patient characteristics 
Patient characteristics are described in more detail in Chapter 4.  Average resting 
BDNF levels at baseline were 28690 (± 6870) ng/ml and average change score from pre- 
to post-exercise was 5265 (± 10993) ng/ml.  The baseline average amount of METs of 
vigorous and moderate intensity exercise completed was 359 (± 405) for the overall 
sample. The average amount of METs of exercise completed over the course of the full 
study was 5381 (± 4071).  There was not a significant difference between intervention 
conditions (i.e., exercise vs. stretching) in total METs of exercise completed across the 
study (t(29) = 0.22, p = 0.83, d = 0.08). 
Effects on BDNF changes across an individual exercise session 
In a one-sample t-test, BDNF change scores across assessment points during the 
study were shown to significantly increase (t(80) = 4.61, p < 0.001, d = 0.83), as 
hypothesized.  At each assessment point, BDNF levels increased significantly across an 
individual session of exercise as evaluated by repeated measure t-test: baseline: t(24) = 
2.40, p = 0.025, d = 0.96; Week 4: t(20) = 2.24, p = 0.037, d = 1.01; Week 8: t(19) = 
2.15, p = 0.044, d = 1,00; Week 16: t(14) = 2.33, p = 0.036, d = 1.16.    
In a mixed effects model examining effects of time, intervention condition (i.e., 
exercise vs. stretching), and their interaction on changes in BDNF from pre- to post-
exercise, neither of the main effects (all p > 0.46) nor the interaction (p = 0.74) were 
significant, consistent with the absence of differences in exercise levels between 
 
 
 
 
 68 
conditions.  When the amount of moderate and vigorous intensity exercise was 
substituted for intervention condition as a predictor, all effects remained non-significant 
(all p > 0.13); however, the interaction between METs of activity and time increased to a 
moderate effect size (F(3, 25) = 2.06, p = 0.13, d = 0.53).    
Effects on resting BDNF levels 
A similar mixed effects model was conducted with resting BDNF levels (those 
collected prior to the exercise test) as the repeated dependent variables and time, 
condition, and their interaction as predictors.  Results indicated no significant main 
effects (all p > 0.71) or interaction (p = 0.75).  When replacing intervention condition 
with total amount of moderate and vigorous intensity exercise completed, again all results 
were non-significant; however, the interaction between METs of exercise and time 
increased to a moderate effect size (F(3, 28) = 1.64, p = 0.20, d = 0.49). 
Effects of BDNF on depression 
The change in resting BDNF across the study period (baseline to endpoint) was 
not associated with the degree of change in depression as assessed by the MADRS (r = -
0.19, p = 0.49) or the BDI-II (r = 0.25, p = 0.34).  Likewise, the endpoint change in 
BDNF across exercise was not associated with changes in depression as assessed by 
either the MADRS (r = 0.35, p = 0.21) or the BDI-II (r = -0.26, p = 0.35). 
Effects of BDNF on cognition 
 The change in resting BDNF was also not associated with cognitive outcomes of 
attention assessed via average CPT-IP performance (r = -0.23, p = 0.40) or memory 
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(immediate recall: r = 0.20, p = 0.46; delayed recall: r = 0.33, p = 0.23; recognition: r = -
0.063, p = 0.82).  Likewise, the endpoint change in BDNF across exercise was not 
associated with changes in attention (r = 0.22, p = 0.42) or memory (immediate recall: r = 
-0.071, p = 0.80; delayed recall: r = -0.16, p = 0.58; recognition: r = 0.10, p = 0.73). 
Discussion 
 This study aimed to extend findings from a recent meta-analytic review (Szuhany 
et al., 2015) that demonstrated reliable moderate effects sizes for increases in pre- to post-
exercise BDNF levels following both acute and programs of exercise to a group of 
depressed outpatients.  Results, consistent with the meta-analysis, showed significant 
increases in BDNF levels across a single exercise session at each of the four assessment 
points.  Though not significant, this study found a moderate effect size (d = 0.53) for the 
interaction between amount of exercise completed and time on changes in BDNF levels 
from pre- to post-exercise.  This effect size is consistent with the effect size (Hedges’ g = 
0.58) found in the meta-analysis.  I also found a non-significant, but moderate effect (d = 
0.49) for the interaction between amount of exercise and time on resting BDNF levels, an 
effect somewhat larger than that (Hedges’ g = 0.28) found in the meta-analysis. Hence, 
even though the study was underpowered to reach significance for effects of this size, this 
study showed generally consistent effects to those documented in my quantitative review. 
 Previous research on the effect of acute exercise on BDNF has focused primarily 
on physically and mentally healthy individuals (Dinoff et al., 2017), though, as noted, 
BDNF changes may be particularly important for depressed populations.  The current 
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study found a significant change in the range of a large effect size (d = 0.83) in BDNF 
levels at each of the four time points from pre- to post-exercise.  These results are 
consistent with meta-analytic results for diverse samples of participants (Hedges' g = 
0.46, Szuhany et al., 2015), as well as two previous studies assessing BDNF change 
across a single exercise session in depressed patients (Gustafsson et al., 2009; Laske et 
al., 2010).  Gustafsson and colleagues (2009) noted a larger change in BDNF across 
exercise in males (487 pg/ml to 1627 pg/ml) versus females (367 pg/ml to 642 pg/ml).  
Laske and colleagues (2010) found that BDNF increases following exercise in depressed 
patients brought them to the resting BDNF levels exhibited by non-depressed controls. 
 Though BDNF levels significantly changed following acute exercise, these 
changes were not associated with changes in depression symptoms.  Though this result 
was contrary to original hypotheses, at least two other studies have found lack of 
correspondence between changes in BDNF and changes in depression: one across a 
program of exercise (Toups et al., 2011) and one during acute exercise (Meyer, Koltyn, 
Stegner, Kim, & Cook, 2016).  It is unclear why some studies of depressed patients show 
an association between changes in BDNF with changes in depression following a 
program of exercise (Kerling et al., 2017) while others do not (Toups et al., 2011).  In the 
current study, participants had two potential sources of benefit to their depression 
symptoms:  BA and exercise.  Thus, the mechanism of improvement may have been 
diffused.  Results discussed in Chapter 3 also indicate that BA appears to be the stronger 
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source of antidepressant benefit as there were no differential effects between adjunctive 
conditions (i.e., exercise and stretching).   
 Several factors may have limited this study’s ability to produce results 
corresponding to previous literature.  First, the sample size was limited both by the pilot 
nature of the study as well as the inability to obtain blood samples from some 
participants.  This limited sample size may have interfered with the ability to find 
significant interactions of exercise and time on BDNF levels as well as BDNF 
associations with depression.  Second, pre- and post-exercise BDNF levels were collected 
following administration of a maximal exercise test.  Individuals self-identify when to 
end this test at when they feel they have reached their “maximum” capacity.  This allows 
for the test to be longer or shorter and more or less intense depending on the individual, 
which may have contributed to variable BDNF effects.  
 The limitations of the current study reveal methodological considerations 
important for future study planning.  First, this includes recruiting a larger study sample 
and standardizing the exercise test.  In addition to a larger sample size overall, I 
recommend that comparable samples of men and women are included in order to assess 
for moderation effects as past studies have indicated that BDNF responds differently in 
the sexes.  Specifically, meta-analyses demonstrate that exercise has a larger effect on 
BDNF in men than in women (Dinoff et al., 2017; Szuhany et al., 2015).  Other 
considerations include examining BDNF changes across a program of exercise in 
clinically depressed and non-depressed participants.  This may allow for identification of 
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whether BDNF changes are more pronounced in one population versus the other.  
Additionally, effects on both clinical and subclinical depression can be assessed.  Finally, 
given the potential potency of BA for increasing exercise and enhancing mood, it may be 
interesting to analyze the effects of BA sans a specific exercise prescription on BDNF 
levels and subsequent changes in depression.  This may allow for better isolation of 
BDNF impact on depression. 
 Overall, this study adds to the literature showing reliable effects of acute exercise 
on increasing BDNF levels and extends this research to the infrequently studied 
depressed population.   
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Chapter 5.  General Discussion 
 My goals for this series of studies were to evaluate the feasibility, acceptability, 
and efficacy of an exercise augmentation for brief behavioral activation (BA).  Using the 
framework of this randomized, controlled clinical trial as well as a meta-analytic review, 
I also examined a potential biological mechanism of action, brain-derived neurotrophic 
factor (BDNF), by which exercise exerts its effects on both mood and cognition.  Given 
its demonstrated efficacy as a stand-alone intervention, exercise could exert more 
powerful effects in combination with an empirically-supported treatment, such as BA.  
Thus, this combination could prove more cost-effective and time-limited.  However, the 
results from the clinical trial in this series provided preliminary evidence that a prescribed 
exercise intervention in addition to BA may not confer added efficacy, specifically 
beyond BA plus a stretching comparison condition.  Clinical implications of this result 
will be discussed in greater detail in the following sections.  
 Examining BDNF, a possible mechanism of change, serves to delineate potential 
biological pathways by which exercise exerts effects on both mood and cognition.  The 
current series of studies examined this mechanism through meta-analysis and a clinical 
trial.  In the clinical trial, there was not a significant association between exercise, 
changes in BDNF, and changes in depressed mood.  However, it represents one of the 
few studies to examine this effect in a depressed population.  Given the promising results 
of the meta-analysis suggesting BDNF changes following exercise in primarily healthy 
populations, it may be important to continue to study this association in psychiatric 
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populations.  More detailed suggestions for future research will be discussed in the 
following sections.   
Clinical Implications 
 The results from these studies have a variety of implications for clinical practice.  
In the clinical trial, the combination of an empirically-supported psychosocial treatment 
(BA) with exercise did not enhance outcomes for depressed mood, as originally 
hypothesized.  All patients, regardless of augmentation condition—exercise or 
stretching—significantly improved in depression, quality of life, distress intolerance, and 
perceived stress over time.  Further, all patients completed more moderate and vigorous 
intensity exercise over the course of the trial, regardless of group assignment.  This 
suggests that utilizing the BA framework may increase not only activity level in general, 
but also exercise specifically.  Therefore, a specific exercise prescription above and 
beyond BA may not be necessary.  Pilot data from a study of 29 depressed women with 
Type 2 diabetes suggested a similar conclusion:  utilizing behavioral activation strategies 
in a group format increases exercise levels over time (Schneider et al., 2016).  
 One source of the efficacy of BA may lie in increased physical activity which 
subsequently improves depressed mood.  Yet, adding an exercise prescription to BA (in 
comparison to stretching plus BA) did not enhance effects on depression symptoms.  
Results from the clinical trial (see Chapter 4), however, indicate that a specific exercise 
prescription may uniquely confer benefit to DI and perceived stress.  As such, exercise 
may provide additional benefits to patients with comorbid anxiety disorders, since higher 
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levels of DI and perceived stress tend to co-occur with these diagnoses.  Research has 
indicated that exercise also improves symptoms of anxiety (Stonerock, Hoffman, Smith, 
& Blumenthal, 2015; Stubbs et al., 2017; Wipfli, Rethorst, & Landers, 2008), though not 
all reviews are in agreement as at least one meta-analysis finds a non-significant effect of 
aerobic exercise on anxiety (Bartley, Hay, & Bloch, 2013).  Further, at least one study 
has examined the effect of exercise in combination with CBT for anxiety (i.e., social 
anxiety, generalized anxiety, panic) and has shown that this augmentation is helpful in 
improving depression, anxiety, and stress over the course of 8 to 10 weeks (Merom et al., 
2008).  BA may not only serve as a tool for improving withdrawal commonly noted in 
individuals with depression but may also serve as a tool for exposure for individuals 
avoiding situations due to anxiety.  A study in both anxious and depressed youth found 
that a behavioral activation intervention emphasizing anti-avoidance and exposure led to 
greater posttreatment remission rates in both depression and anxiety diagnoses (Chu et 
al., 2016).  Given this preliminary evidence, clinicians may choose to use behavioral 
activation as a transdiagnostic treatment for individuals with comorbid depression and 
anxiety. 
 Finally, given the increases in quality of life and general well-being exhibited for 
patients over the course of the study, BA, and possibly exercise alone, may be useful 
strategies to implement to increase life satisfaction.  Clinicians may consider adding 
exercise or components of brief BA to other psychosocial interventions or medication 
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management as these represent brief, cost-effective, and easy interventions to not only 
improve symptomatology but also well-being. 
Conclusions and Future Directions 
 This multi-study investigation has added to the literature on the efficacy of brief 
behavioral activation treatment for individuals with primary depressive disorders.  It has 
also raised questions of the conceptualization of BA as a framework by which to increase 
overall activity including moderate-intensity exercise (see Chapter 3).  Finally, the meta-
analysis (see Chapter 2) suggests that both acute and regular exercise cause increases in 
BDNF levels; however, the clinical trial (see Chapter 4) did not clarify the direct 
relationship among exercise, BDNF, and depression symptoms.   
 Since the conclusion of this study, several meta-analyses have examined effects of 
exercise on cognition in various populations.  For example, Northey and colleagues 
(2017) found that across 39 studies, exercise improved cognitive function (i.e., global 
cognition, attention, executive function, memory, working memory) in community 
dwelling adults over the age of 50.  Even more promising, a recent meta-analysis 
including 10 trials found significant effects of exercise on cognition (i.e., global 
cognition, working memory, social cognition, attention/vigilance) in patients with 
schizophrenia (Firth, Stubbs, et al., 2017).  Patients received most benefit in terms of 
completing more exercise when interventions were supervised.  Another meta-analysis of 
29 studies found that exercise improved symptom severity (including positive and 
negative symptoms of schizophrenia), quality of life, global functioning, and depression 
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symptoms in patients with schizophrenia (Dauwan, Begemann, Heringa, & Sommer, 
2016).  However, only yoga improved the specific cognitive domain of long-term 
memory.  Exercise overall did not show effects on cognition.  As cognitive deficits cause 
significant difficulties in functioning in patients with schizophrenia, utilizing exercise as 
a tool for improving health, cognition, and mood may be quite beneficial for this 
population.  Improving cognition may also be particularly relevant to improvement in 
quality of life, such as job attainment, which may not be examined specifically in the 
context of a brief clinical trial.  For example, improvements in cognition in patients with 
schizophrenia via cognitive rehabilitation has been shown to increase total time spent 
working over the course of a three-year trial (McGurk et al., 2016).    
Findings seem to be inconclusive, however, for identifying the association 
between exercise, BDNF increases, and cognitive enhancement in schizophrenia.  A 
recent review identified an association between exercise and increased brain volume in 
individuals with schizophrenia (Firth, Cotter, Carney, & Yung, 2017).  Further, at least 
one study found that increased exercise was positively correlated with both BDNF 
increases and cognitive enhancement (Kimhy et al., 2015).  In this study, increases in 
BDNF accounted for 14.6% of improvements in cognitive performance from exercise.  
However, most studies did not explore this mechanistic link. 
 Likewise, a complex relationship between exercise, cognition, and BDNF exists 
in patients with a primary depressive disorder.  A recent meta-analysis of eight trials 
including depressed patients found no significant overall effects of exercise on global 
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cognition or specific domains of cognition (Brondino et al., 2017).  However, individual 
trials have shown effects of exercise on cognitive domains, such as memory and 
executive functioning, in depressed adults (e.g., Khatri et al., 2001).  In regards to the 
relationship between exercise, BDNF, and cognition, the clinical trial (Chapter 4) did not 
identify a significant association among these variables.  Other studies have also failed to 
demonstrate this association (Kerling et al., 2017; Meyer et al., 2016; Toups et al., 2011).   
As there is currently conflicting evidence and only few rigorous trials exist 
examining the effects of exercise on cognitive domains in both patients with 
schizophrenia and depression, there is value in prioritizing these patient populations in 
future research.  Given the cognitive deficits that often malign these populations, having 
an easily accessible intervention to target mood, cognition, and health may contribute to 
decreased disability and increased quality of life.  Additionally, it may be beneficial to 
clarify the nature of the relationship between exercise, BDNF changes, and changes in 
depression/cognition.  It would be valuable to identify whether BDNF changes precede 
changes in depression/cognition or vice versa to better establish the pathway by which 
exercise exerts its effects in the brain. 
 Several other methodological considerations remain to be explored in future 
research.  First, as BA may provide a context for increases in exercise, it would be 
beneficial to examine the magnitude of this potential effect.  Therefore, it is 
recommended that exercise completion is monitored in future BA research.  Participants 
may be administered the 7-Day Physical Activity Recall, as utilized in Chapters 3 and 4, 
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or the self-report International Physical Activity Questionnaire (Craig, Marshall, 
Sjöström, et al., 2003) to assess weekly exercise completion rates.  Second, BA may 
serve as exposure for individuals with anxiety disorders, most specifically social anxiety 
or panic disorder/agoraphobia; thus, integrating measures of anxiety into BA clinical trial 
batteries may be warranted and fruitful.  Third, as exercise has been shown to be an 
efficacious intervention for both mood and anxiety disorders, it may be beneficial to 
administer brief exercise interventions in group fashion.  A brief group exercise 
intervention may be particularly effective as an adjunct to weekly outpatient 
psychotherapy or as a standard group in a partial hospital program.  Indeed, a recent 
study explored utilizing a one-session group format in a partial hospital setting and a 
three-setting group format is undergoing investigation in a diverse outpatient setting.  The 
one-session intervention was useful in increasing exercise in patients with serious mental 
illness in a partial hospitalization program (Hearon et al., 2016). 
 The pilot randomized controlled trial (Chapters 3 and 4) included a strong 
representation of minority populations; however, given sample size, identifying 
interactions among treatment outcome and race/ethnicity was limited.  However, it may 
be beneficial to extend examination of effects of exercise and BA on mood in culturally 
diverse and chronically medically ill populations.  Recent estimates from the Centers for 
Disease Control indicate that approximately 26% of the total population does not engage 
in regular leisure time physical activity but this number is increased to 31% in both black 
and Hispanic populations as compared to 24% for whites.  Therefore, there is a need not 
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only to utilize interventions that target exercise but also motivation to exercise as several 
barriers, including time, medical comorbidities, and poor neighborhood conditions, exist.  
Future studies may choose to adapt the exercise intervention to be more culturally 
sensitive as well as to specifically target these barriers by using creative strategies (e.g., 
working with community centers or churches).  Similarly, the exercise intervention may 
be adapted to be more conducive to medically ill populations.  For example, as sleep is a 
common concern for both medical and psychiatric populations, utilizing exercise 
systematically as an intervention to improve sleep may be warranted.  Indeed, a recent 
meta-analysis suggests that exercise has benefits for total sleep time and sleep efficiency 
(Kredlow et al., 2015).  Additionally, assessing sleep as a potential mediator within 
studies of both BA and exercise may be warranted. 
 In summary, there continues to exist a need for cost-effective, time-limited, and 
easily accessible interventions for individuals with depression as some individuals do not 
respond to current first-line treatments.  Exercise has been shown to offer benefits to 
mood, health, and quality of life and potentially could intensify these benefits when 
utilized in conjunction with the brief empirically-supported treatment of behavioral 
activation.  The current series of studies raised questions of the role of BA in increasing 
exercise among depressed, sedentary patients without the need for a specific exercise 
prescription.  Through meta-analysis, exercise was shown to reliably increase BDNF 
levels both acutely following exercise as well as increase resting BDNF levels across a 
program of regular exercise.  However, it remains unclear the nature of the relationship 
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between increases in BDNF produced by exercise and subsequent changes in depression 
symptoms.  This investigation has contributed to the literature on brief, cost-effective 
interventions for depression and highlights the complicated nature and need for more 
research in the areas of mechanisms of change. 
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Table 1. Sample characteristics at the baseline assessment. 
 Exercise 
N = 15 
Stretching 
N = 17 
p 
 
Age 30.5 (12.7) 36.5 (13.7) 0.21 
Number (percent) female 10 (67%) 15 (88%) 0.14 
Number (percent) nonwhite* 12 (13.8%) 1 (6%) 0.96 
Number (percent) race 
   Caucasian 
   Asian 
   African American 
   Other 
 
8 (53%) 
3 (20%) 
0 (0%) 
4 (27%) 
 
11 (65%) 
4 (23%) 
2 (12%) 
0 (0%) 
0.09 
Number (percent) education 
   Completed High School 
   Some College 
   Completed College 
   Graduate Degree 
 
0 (0%) 
5 (33%) 
8 (53%) 
2 (13%) 
 
2 (12%) 
7 (41%) 
5 (29%) 
3 (18%) 
0.38 
Principal Diagnosis 
   MDD 
   PDD 
 
10 (67%) 
5 (33%) 
 
11 (65%) 
6 (35%) 
0.91 
Co-principal diagnosis 
   GAD 
 
2 (13%) 
 
3 (18%) 
0.47 
 
 
 
 
 83 
   Social anxiety 2 (13%) 1 (6%) 
Secondary diagnoses 
   Social anxiety 
   GAD 
   Specific phobia 
   Panic disorder 
   PTSD 
   OCD 
   Agoraphobia 
   BDD 
   Separation 
   ADHD 
 
7 (47%) 
5 (33%) 
1 (7%) 
1 (7%) 
0 (0%) 
0 (0%) 
1 (7%) 
1 (7%) 
1 (7%) 
2 (13%) 
 
8 (47%) 
5 (29%) 
3 (18%) 
2 (12%) 
2 (12%) 
2 (12%) 
1 (6%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
MADRS 24.7 (8.1) 27.0 (7.8) 0.43 
BDI-II 26.4 (10.9) 27.5 (9.8) 0.77 
WSAS 24.8 (8.6) 24.1 (7.4) 0.80 
Q-LES-Q 39.3 (7.6) 39.6 (8.4) 0.91 
DII 17.4 (10.4) 20.5 (7.2) 0.33 
PSS 25.1 (5.4) 25.3 (6.0) 0.94 
METs vigorous & moderate PA 279.5 (371.7) 429.2 (431.3) 0.31 
CPT-IP 3.1 (0.49) 2.8 (0.63) 0.21 
WMS-IV Logical Memory    
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   LM I 
   LM II 
   LM Recognition 
29.7 (7.4) 
26.6 (8.3) 
26.3 (2.3) 
26.1 (5.9) 
23.1 (5.5) 
25.0 (2.6) 
0.13 
0.16 
0.16 
Note. p values derived from χ2 tests for race and education and t tests for all other 
comparisons. MDD = major depressive disorder, PDD = persistent depressive disorder, 
GAD = generalized anxiety disorder, PTSD = posttraumatic stress disorder, OCD = 
obsessive compulsive disorder, BDD = body dysmorphic disorder, ADHD = attention 
deficit hyperactivity disorder, MADRS = Montgomery-Asberg Depression Rating Scale, 
BDI-II = Beck Depression Inventory-II, WSAS = Work and Social Adjustment Scale, Q-
LES-Q = Quality of Life Enjoyment Questionnaire, DII = Distress Intolerance Index, 
PSS = Perceived Stress Scale, METs = metabolic equivalents, PA = physical activity, 
CPT-IP = Continuous Performance Test-Identical Pairs, WMS = Wechsler Memory 
Scale, LM = Logical Memory. 
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Table 2. Results of Multiple Regression Analyses: Group, Time, and Interaction Effects for Each Outcome Measure 
(Chapter 3) 
Outcome Group 
F(df) 
 
d 
Time 
F(df) 
 
d 
Interaction 
F(df) 
 
d 
Clinician-rated 
Depression: MADRS 
0.88 (1, 29) 0.33 11.30 (4, 21)*** 1.19 0.99 (4, 21) 0.35 
Self-reported 
Depression: BDI-II 
0.007 (1, 22) 0.23     10.77 (4, 18)*** 1.16 1.39 (4, 18) 0.42 
Quality of Life: Q-
LES-Q 
0.54 (1, 26) 0.26 8.92 (4, 20)*** 1.06 1.94 (4, 20) 0.49 
Functional Impairment: 
WSAS 
Distress Intolerance: 
DII 
0.08 (1, 29) 
 
0.16 (1, 26) 
0.32 (1, 31) 
0.10 
 
0.14 
0.20 
6.08 (4, 20)** 
 
4.85 (4, 22)** 
8.78 (4, 21)*** 
0.87 
 
0.78 
1.05 
1.24 (4, 20) 
 
3.89 (4, 22)* 
2.85 (4, 21)* 
0.39 
 
0.70 
0.60 
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Perceived Stress: PSS 
METs of exercise 
Stretching minutes 
Logical Memory I 
Logical Memory II 
Logical Memory 
Recognition 
Attention: CPT-IP 
0.78 (1, 22) 
20.67 (1, 
27)*** 
2.52 (1, 28) 
1.31 (1, 28) 
3.33 (1, 30)† 
 
0.25 (1, 17) 
0.31 
1.61 
0.56 
0.41 
0.65 
 
0.18 
4.66 (4, 21)** 
5.06 (4, 23)** 
5.98 (2, 15)* 
19.47 (2, 16)*** 
8.16 (2, 20)** 
 
1.10 (2, 6) 
0.76 
0.80 
0.87 
1.56 
1.01 
 
0.37 
0.73 (4, 21) 
8.10 (4, 23)*** 
0.24 (2, 15) 
0.08 (2, 16) 
0.16 (2, 20) 
 
2.42 (2, 6) 
0.30 
1.01 
0.17 
0.10 
0.14 
 
0.55 
_________________________________________________________________________________________________ 
Note.  MADRS = Montgomery-Asberg Depression Rating Scale, BDI-II = Beck Depression Inventory-II, Q-LES-
Q = Quality of Life Enjoyment Satisfaction Questionnaire, WSAS = Work and Social Adjustment Scale, DII = 
Distress Intolerance Index, PSS = Perceived Stress Scale, METs = metabolic equivalents of moderate and vigorous 
intensity exercise, LM = Logical Memory, CPT-IP = Continuous Performance Test-Identical Pairs. All regression 
analyses included time, group, and group by time interaction. *p < 0.05, **p < 0.01, ***p < 0.001, †p<0.10 
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Figure 1. Study selection process (Chapter 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Studies selected for screening 
(n = 61) 
Studies (n = 11) excluded for the 
following reasons:  
Focus on genetic BDNF data (n = 
6) 
Irrelevant paradigms (e.g., no 
measure of BDNF changes with 
exercise) (n = 4) 
Review or qualitative paper (n = 1) 
Self-reported exercise (n = 6) 
 
Studies to be considered for 
inclusion in meta-analysis  
(n = 44) 
Studies excluded because required 
data were incomplete and authors 
could not provide supplementary 
data (n = 14) 
 
Studies included in the meta-
analysis (n = 30) 
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Figure 2. Effect sizes of the association between exercise and BDNF levels following 
acute exercise (Chapter 2) 
 
Note. s, serum; a, acute exercise 
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Figure 3. Effect sizes of the association between acute exercise and BDNF levels 
following programmed regular exercise (Chapter 2) 
 
Note. c, change after programmed exercise 
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Figure 4. Effect sizes of the association between exercise and resting BDNF levels 
following programmed regular exercise (Chapter 2) 
 
Note. s, serum; r, resting BDNF levels after programmed exercise 
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Figure 5. Association between average effect size of combined pool of studies and 
percentage of female participants (Chapter 2) 
 
Note. Having more female participants significantly decreased the effect of exercise on 
BDNF levels 
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Figure 6. CONSORT diagram (Chapter 3)
 
Figure 7.  Metabolic equivalents of moderate and vigorous intensity exercise by group 
over time (Chapter 3) 
Phone Screened 
(n=116)
Scheduled for 
Screening (n=44)
Randomized
n = 31
Exercise
n = 15
Completed intervention and 
post-treatment assessment
n = 11
Completed through 1-
month follow-up
n = 9
Dropped during 
follow-up
n = 2
*unable to contact 
(n=1)
*too busy to 
continue (n=1)
Dropped during acute 
treatment (before session 
6)
n= 4
*lost to follow-up (n=1)
*preferred alternate 
treatment (n=1)
*felt improved (n=1)
*too busy to continue 
(n=1)
Stretching
n = 16
Completed intervention 
and post-treatment 
assessment
n = 13
Completed through 1-
month follow-up
n=12
Dropped during 
follow-up
n=1
*preferred alternate 
treatment (n=1)
Dropped during acute 
treatment (before session 
6)
n = 3
*lost to follow-up (n=1)
*too busy to continue 
(n=2)
Excluded at Screening (n=4)
*High suicide risk according to C-
SSRS (n =1)
*Medical exclusion (n =1 )
*Did not meet criteria for depression 
(n =1)
Dropped before consent 
(n=6)
*Did not attend scheduled 
visit (n=4)
*Declined to participate 
prior to consenting (n=2)
Dropped before 
randomization (n=3)
Not Scheduled 
(n=72)
*not sedentary (n=19)
*no longer interested in 
study (n=16)
*lost to follow-up (n=8)
*not enough depression 
symptoms (n=8)
*CBT in past 3 months 
(n=5)
*not located in area 
(n=4)
*medical condition 
(n=3)
*not available for 
entirety of study (n=3)
*diagnosed with bipolar 
(n=3)
*high suicide risk (n=2)
*diagnosed with eating 
disorder (n=1)
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Figure 8. Clinician-rated depression as assessed by the MADRS by group over time 
(Chapter 3) 
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Figure 9. Self-reported depression as assessed by the BDI-II by group over time (Chapter 
3) 
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Figure 10. Quality of life as assessed by the Q-LES-Q by group over time (Chapter 3) 
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Figure 11. Functional impairment as assessed by the WSAS by group over time (Chapter 
3) 
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Figure 12. Distress intolerance as assessed by the DII by group over time (Chapter 3) 
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Figure 13. Perceived stress as assessed by the PSS by group over time (Chapter 3) 
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